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1. Materials and Methods.  Unless otherwise stated, reactions were performed under a nitrogen 
atmosphere using freshly dried solvents. Methylene chloride, deuterated methylene chloride, 
dioxane, ether, tetrahydrofuran, and toluene were dried by passing through activated alumina. 
Dichloroethane and chloroform were distilled over calcium hydride.  Powdered 4Å molecular 
sieves were flame-dried under vacuum immediately prior to use.  Potassium carbonate was dried 
for 12 h at 130 °C under vacuum and 2,6-lutidine was distilled over AlCl3.  All other 
commercially obtained reagents were used as received unless specifically indicated. (R)-BINOL 
(9a), 2-phenylindole (6a) and 2-methylindole (6r) were purchased from Alfa Aesar, N-methyl-2-
phenylindole (6b) was obtained from Sigma-Aldrich, and 1 M SnCl4 in CH2Cl2 was purchased 
from Acros Organics. (R)-3,3’-diphenyl-BINOL (9b),1 (R)-3,3’-dimethyl-BINOL (9c),2 (R)-3,3’-
dichloro-BINOL (9e)3, (R)-3,3’-dibromo-BINOL (9f),4 (R)-3,3’-dimethoxy-BINOL (9g),4 (R)-
6,6’-dimethyl-BINOL (9i)5 and  (R)-6,6’-dibromo-BINOL (9j)6 were prepared according to 
literature procedures.  All reactions were monitored by thin-layer chromatography using 
EMD/Merck silica gel 60 F254 pre-coated plates (0.25 mm). Silica gel column chromatography 
was performed either as described by Still et al. (Still, W. C.; Kahn, M.; Mitra, A. J. Org. Chem. 
1978, 43, 2923.) using silica gel (particle size 0.032-0.063) purchased from Silicycle or using 
pre-packaged RediSep®Rf columns on a CombiSilica gel Rf system (Teledyne ISCO Inc.).  
Optical rotations were measured on a Jasco P-2000 polarimeter using a 100 mm path-length cell 
at 589 nm.  1H and 13C NMR were recorded on a Varian Inova 500 (at 500 MHz and 125 MHz 
respectively) or a Varian Inova 600 (at 600 MHz and 150 MHz respectively) and are reported 
relative to internal chloroform (1H, δ = 7.26, 13C, δ = 77.0) or internal acetonitrile (1H, δ = 1.94, 
13C, δ = 1.32).  Data for 1H NMR spectra are reported as follows: chemical shift (δ ppm) 
(multiplicity, coupling constant (Hz), integration). Multiplicity and qualifier abbreviations are as 
follows: s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet, br = broad. IR spectra 
were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in frequency of 
absorption (cm–1).  Analytical SFC was performed with a Mettler SFC supercritical CO2 
analytical chromatography system with Chiralcel AD-H, OD-H, AS-H, OB-H, and OJ-H                                                         1 Zhang, X. PCT Int. Appl. WO 2002040491, 2002. 2 Wu, T. R.; Shen, L.; J. M. Chong., J. M. Org. Lett. 2004, 6, 2701. 3 Ito, K.; Takahashi, M.; Hoshino, T.; Nishiki, M.; Ohba. Y. Lett. Org. Chem. 2006, 3, 735. 4 Ooi, T.; Kameda, M.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 5139. 5 Verga, D.; Percivalle, C.; Doria, F.; Porta, A.; Freccero, M. J. Org. Chem. 2011, 76, 2319. 6 Rueping, M.; Sugiono, E.; Steck, A.; Thiessmann, T. Adv. Synth. Catal. 2010, 352, 281. 
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columns (4.6 mm x 25 cm).  HRMS were acquired using either an Agilent 6200 Series TOF with 
an Agilent G1978A Multimode source in electrospray ionization (ESI), atmospheric pressure 
chemical ionization (APCI) or mixed (MM) ionization mode, or obtained from the Caltech Mass 
Spectral Facility. 
Abbreviations used: BINOL – 1,1’-bi(2-naphthol); IPA – isopropanol; Et2O – diethyl ether; 
PhMe – toluene; EtOAc – ethyl acetate; DCE – dichloroethane; DCM – dichloromethane; MeCN 
– acetonitrile; ee – enantiomeric excess 
 
2. Catalyst and Substrate Preparation. 
Preparation of (R)-3-chloro-BINOL (9d) 
 
OMOM
OMOM
OMOM
OMOM
Cl
n-BuLi, Et2O, 23 ºC;
then C2Cl6, –78 ºC ! 23 ºC
S1 S2
(40% yield)  
To a flame-dried 100 mL flask containing MOM–protected (R)-BINOL S12 (748 mg, 2.00 mmol, 
1.00 equiv) was added Et2O (45 mL), followed by dropwise addition of n-BuLi as a solution in 
hexanes (2.5 M, 960 µL, 2.40 mmol, 1.20 equiv) at room temperature.  The mixture was then 
stirred at room temperature for 3 h and subsequently cooled to –78 ºC, followed by addition of 
C2Cl6 (569 mg, 2.40 mmol, 1.20 equiv) in one portion.  The reaction mixture was allowed to 
warm to room temperature over 3 h, then diluted with EtOAc (15 mL) and washed with saturated  
aqueous NH4Cl (50 mL). The aqueous layer was extracted with EtOAc (45 mL) and the 
combined organic layers were dried (Na2SO4), filtered and concentrated.  The crude yellow oil 
was purified by silica gel chromatography (0:100 to 12:88 EtOAc:hexanes) to yield 328 mg 
(40% yield) of S2 as a white solid.  1H NMR (500 MHz, CDCl3) δ 8.05 (s, 1H), 7.97 (d, J = 9.0 
Hz, 1H), 7.87 (d, J = 8.1 Hz, 1H), 7.81 (d, J = 8.2 Hz, 1H), 7.59 (d, J = 9.1 Hz, 1H), 7.42 (ddd, J 
= 8.1, 6.7, 1.3 Hz, 1H), 7.37 (ddd, J = 8.1, 6.8, 1.2 Hz, 1H), 7.28 (ddd, J = 8.2, 6.8, 1.3 Hz, 1H), 
7.24 (ddd, J = 8.5, 6.7, 1.3 Hz, 1H), 7.18 (dddd, J = 8.6, 1.3, 0.7, 0.7 Hz, 1H), 7.16 (ddd, J = 8.5, 
1.8, 0.8 Hz, 1H), 5.15 (d, J = 7.0 Hz, 1H), 5.04 (d, J = 7.0 Hz, 1H), 4.80 (d, J = 5.6 Hz, 1H), 4.75 
(d, J = 5.6 Hz, 1H), 3.19 (s, 3H), 2.71 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 152.9, 148.9, 
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133.8, 132.6, 131.1, 130.0, 129.5, 128.8, 128.0, 127.9, 127.8, 127.0, 126.7, 126.4, 126.1, 125.8, 
125.5, 124.2, 119.9, 116.3, 98.8, 94.9, 56.5, 55.9; IR (NaCl/thin film): 2955, 2902, 1594, 1508, 
1354, 1241, 1159, 1149, 1034, 1014, 961, 922 cm-1; [α]D25 = +69.1 (c = 0.90, CHCl3). HRMS 
(FAB+) calc’d for M+ 408.1128, found 408.1128. 
 
Cl
OMOM
OMOM
OH
OH
Cl
conc. HCl, Dioxane, 50 ºC
S2 9d
(87% yield)
 
A 10 mL flask was charged with S2 (305 mg, 0.75 mmol, 1.00 equiv), dioxane (3.7 mL) and 
aqueous HCl (12 M, 130 µL, 1.58 mmol, 2.10 equiv), then heated to 50 ºC for 2 h.  The mixture 
was cooled to room temperature, then diluted with H2O (30 mL) and extracted with EtOAc (6 x 
20 mL).  The combined organic layers were dried (Na2SO4), filtered and concentrated.  The 
crude residue was purified by silica gel chromatography  (0:100 to 20:80 EtOAc:hexanes) to 
yield 210 mg (87% yield) of (R)-3-chloro-BINOL (9d) as a white foam, which was dried over 
P2O5 under vacuum. 1H NMR (500 MHz, CDCl3) δ 8.09 (s, 1H), 7.97 (d, J = 8.9 Hz, 1H), 7.90 
(d, J = 8.1 Hz, 1H), 7.83 (d, J = 8.2 Hz, 1H), 7.45 – 7.35 (m, 3H), 7.34 – 7.28 (m, 2H), 7.16 (d, J 
= 8.5 Hz, 1H), 7.11 (d, J = 8.4 Hz, 1H), 5.60 (s, 1H), 4.94 (s, 1H); 13C NMR (125 MHz, CDCl3) 
δ 152.1, 148.3, 133.1, 132.4, 131.3, 129.7, 129.32, 129.26, 128.4, 127.7, 127.5, 127.3, 125.1, 
124.6, 124.1, 123.9, 122.4, 117.7, 113.6, 111.7; IR (NaCl/thin film): 3503, 3057, 1620, 1596, 
1502, 1451, 1379, 1265, 1212, 1184, 1146, 828 cm-1; [α]D25 = +55.4 (c = 1.01, CHCl3). HRMS 
(MM) calc’d for [M-H]- 319.0531, found 319.0549. 
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Preparation of (R)-6,6’-dimethoxy-BINOL (9h) 
 
OMOM
OMOM
OMOM
OMOM
(i)  n-BuLi, THF, –78 ºC;
 B(OMe)3, –78 ! 23 ºC
S3 S4
Br
Br
(ii) H2O2, PhH, 0 ! 80 ºC
HO
HO
(61% yield)  
(R)-6,6’-dimethoxy-BINOL (9h) was prepared following a procedure adapted from a reported 
synthesis of (R)-3,3’-dimethoxy-BINOL (9g).4  To a 25 mL flask containing MOM–protected 
(R)-6,6’-dibromo-BINOL S36 (1.10 g, 2.07 mmol, 1.00 equiv) was added THF (6.3 mL).  The 
flask was cooled to –78 ºC, followed by dropwise addition of n-BuLi as a solution in hexanes 
(2.5 M, 2.50 mL, 6.20 mmol, 3.00 equiv).  After stirring 1 hour at –78 ºC, B(OMe)3 (645 mg, 
6.20 mmol, 3.00 equiv) was added and the reaction was allowed to warm to room temperature.  
After 14 hours, the reaction mixture was concentrated to give the crude borate intermediate, 
which was suspended in benzene (7.2 mL) and cooled to 0 ºC, followed by dropwise addition of 
aqueous hydrogen peroxide (30 wt %, 0.61 mL, 5.98 mmol, 2.89 equiv).   The suspension was 
heated to reflux for 4 hours, then cooled to room temperature, poured into ice-cold saturated 
aqueous NaSO3 (20 mL), and extracted with EtOAc (3 x 15 mL).  The combined organics were 
washed with brine (30 mL), dried (Na2SO4), filtered, and concentrated.  The crude residue was 
purified by silica gel chromatography (0:100 to 50:50 EtOAc:hexanes) to yield 512 mg (61% 
yield) of S4 as a light yellow foam.  1H NMR (500 MHz, CD3CN) δ 7.80 (ddd, J = 9.1, 0.8, 0.4 
Hz, 2H), 7.51 (d, J = 9.1 Hz, 2H), 7.20 (ddd, J = 2.5, 0.5, 0.5 Hz, 2H), 7.09 (br s, 2H), 6.93 (ddd, 
J = 9.1, 0.7, 0.7 Hz, 2H), 6.87 (dd, J = 9.1, 2.5 Hz, 2H), 5.02 (d, J = 6.7 Hz, 2H), 4.94 (d, J = 6.7 
Hz, 2H), 3.11 (s, 6H) ; 13C NMR (125 MHz, CD3CN) δ 154.4, 151.6, 132.1, 129.6, 128.4, 127.8, 
122.1, 119.6, 118.7, 110.1, 96.0, 56.1; IR (NaCl/thin film): 3368, 2914, 1624, 1599, 1511, 1240, 
1196, 1148, 1023 cm-1; [α]D25 = +87.1 (c = 1.00, MeCN). HRMS (MM) calc’d for [M-H]- 
405.1344, found 405.1350. 
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OMOM
OMOM
OH
OH
(i)  K2CO3, MeI, DMF, 55 ºC
S4 9h
HO
HO
(ii) 3:1:1 THF:IPA:6N HCl,
     23 ºC
MeO
MeO(36% yield)  
A 15 mL flask was charged with S4 (200 mg, 0.493 mmol, 1.00 equiv) and K2CO3 (177 mg, 1.28 
mmol, 2.60 equiv). DMF (2 mL) was added, followed by MeI (123 µL, 1.97 mmol, 4.00 equiv) 
dropwise.  The reaction was then heated to 55 ºC for 22 hours, then cooled to room temperature 
and quenched with saturated aqueous NH4Cl (2 mL) and Et3N (3 drops).  The mixture was 
stirred at room temperature for 6 hours, then diluted with H2O (15 mL) and extracted with 
EtOAc (3 x 10 mL).  The combined organics were washed with brine (15 mL), dried (Na2SO4), 
and concentrated. THF (28 mL) and IPA (9.5 mL) were added to the crude residue, followed by 
dropwise addition of aqueous HCl (6.0 M, 9.4 mL).  The reaction was stirred at room 
temperature for 3 hours, then diluted with H2O (70 mL) and extracted with EtOAc (3 x 30 mL).  
The combined organics were washed with saturated aqueous NaHCO3 (2 x 45 mL) and brine (45 
mL), then dried (Na2SO4), filtered, and concentrated.  The crude oil was purified by silica gel 
chromatography (0:100 to 30:70 EtOAc:hexanes) to yield 62 mg (36% yield) of (R)-6,6’-
dimethoxy-BINOL (9h) as a light brown solid, which was dried over P2O5 under hi-vacuum. 
Spectral data are in agreement with the literature.7 
 
Preparation of 1-allyl-2-phenylindole (6c) 
NaH, allylBr, DMF, 0 ºC
N
H
Ph
N Ph
N Ph
6a 6c S5
(80% combined yield)
 
 
To a 50 mL flask was added NaH (620 mg, 15.5 mmol, 3.00 equiv) and DMF (8 mL) and the 
suspension was cooled to 0 ºC in an ice bath.  A solution of 2-phenylindole 6a (1.00 g, 5.18 
mmol, 1.00 equiv) in DMF (3 mL) was added slowly to the suspension over 15 minutes and the 
reaction mixture was further stirred at 0 ºC for 20 minutes, followed by dropwise addition of                                                         7 Yu, H.-B.; Hu, Q.-S.; Pu, L. J. Am. Chem. Soc. 2000, 122, 6500. 
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allyl bromide (670 µL, 7.77 mmol, 1.50 equiv).  The ice bath was then removed and the mixture 
was stirred for 15 minutes, then quenched by addition of saturated aqueous NH4Cl (5 mL) and 
Et3N (5 drops). After 2 hours, the reaction was diluted with H2O (40 mL) and extracted with 
EtOAc (3 x 30 mL).  The combined organics were washed with brine (120 mL), dried (Na2SO4), 
filtered, and concentrated.  The crude was then purified by reverse phase preparatory HPLC 
(55:45 to 95:5 MeCN:H2O) using an Agilent 1200 Series HPLC with an Agilent XDB-C18 5 µM 
column (9.4 x 250 mm and 21.2 x 150 mm) to yield 687 mg (57% yield) of 1-allyl-2-
phenylindole (6c) as a yellow solid and 331 mg (23% yield) of 1,3-diallyl-2-phenylindole (S5) as 
a yellow oil. 
1-allyl-2-phenylindole (6c): 
1H NMR (500 MHz, CDCl3) δ 7.65 (ddd, J = 7.8, 1.2, 0.8 Hz, 1H), 7.55 – 7.51 (m, 2H), 7.48 – 
7.43 (m, 2H), 7.42 – 7.38 (m, 1H), 7.33 (br d, J = 8.2 Hz, 1H), 7.22 (ddd, J = 
7.0, 7.0, 1.3 Hz, 1H), 7.15 (ddd, J = 7.0, 7.0, 1.0 Hz, 1H), 6.60 (br s, 1H), 6.02 
(ddt, J = 17.2, 10.5, 4.4 Hz, 1H), 5.22 (dtd, J = 10.5, 1.8, 1.1 Hz, 1H), 5.00 
(dtd, J = 17.1, 2.0, 1.2 Hz, 1H), 4.74 (dt, J = 4.2, 1.9 Hz, 2H); 13C NMR (125 
MHz, CDCl3) δ 141.5, 137.8, 133.8, 132.7, 129.1, 128.5, 128.1, 128.0, 121.7, 120.5, 120.0, 
116.5, 110.3, 102.0, 46.5; IR (NaCl/thin film): 3055, 2917, 1602, 1462, 1443, 1392, 1345, 1317, 
1162 cm-1; HRMS (APCI) calc’d for [M+H]+ = 234.1277, found 234.1284. 
 1,3-diallyl-2-phenylindole (S5): 
1H NMR (500 MHz, CDCl3) δ 7.65 (ddd, J = 7.8, 1.2, 0.7 Hz, 1H), 7.50 – 7.40 (m, 5H), 7.33 
(ddd, J = 8.1, 0.9, 0.9 Hz, 1H), 7.24 (ddd, J = 7.0, 7.0, 1.2 Hz, 1H), 7.16 (ddd, 
J = 7.0, 7.0, 1.1 Hz, 1H), 6.05 (ddt, J = 17.0, 10.1, 5.9 Hz, 1H), 5.91 (ddt, J = 
17.1, 10.4, 4.7 Hz, 1H), 5.14 (dtd, J = 10.4, 1.8, 1.2 Hz, 1H), 5.08 – 5.02 (m, 
2H), 4.92 (dtd, J = 17.1, 1.9, 1.3 Hz, 1H), 4.62 (dt, J = 4.6, 1.9 Hz, 2H), 3.46 
(dt, J = 6.0, 1.7 Hz, 2H); 13C NMR (125 MHz, CDCl3) δ 138.0, 137.9, 136.7, 
133.9, 131.8, 130.4, 128.3, 128.2, 128.1, 128.0, 121.7, 119.34, 119.30, 116.2, 114.6, 110.9, 
110.1, 46.4, 29.2; IR (NaCl/thin film): 3056, 2915, 1637, 1463, 1443, 1408, 1360, 1340, 1191 
cm-1; HRMS (MM) calc’d for [M+H]+ = 274.1590, found 274.1591. 
 
N
Ph
6c
N
Ph
S5
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Preparation of 2-(2-fluorophenyl)indole (6p) 
I
NH2
i.  Pd(PPh3)2Cl2, CuI, Et3N, 23 ºC
ii.  InBr3, PhMe, 110 ºC
(77% yield) 6pS6 S7
N
HF
F
 
2-(2-fluorophenyl)indole (6p) was prepared by an analogous procedure to that reported by Sakai 
et. al.8 A flame-dried flask was charged with 2-iodoaniline (S6, 200 mg, 0.90 mmol, 1.00 equiv), 
ethynyl-2-fluorobenzene (S7, 133 mg, 1.10 mmol, 1.20 equiv), Pd(PPh3)2Cl2 (13 mg, 0.02 mmol, 
0.02 equiv), copper (I) iodide (2.0 mg, 0.025 mmol, 0.01 equiv) and Et3N (4 mL).  The mixture 
was stirred overnight at room temperature, then filtered through a plug of silica, concentrated and 
redissolved in PhMe (5 mL).  InBr3 (16 mg, 0.05 mmol, 0.05 equiv) was added in one portion 
and the mixture was heated to 110 ºC for 5 h, then cooled to room temperature, filtered through 
celite, and concentrated.  The crude residue was purified by silica gel chromatography (10:90 
EtOAc:hexanes) to yield 148 mg (77% yield) of  2-(2-fluorophenyl)indole (6p) as a white solid. 
1H NMR (500 MHz, CDCl3) δ 8.89 (br s, 1H), 7.80 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.66 (dddd, J 
= 2.5, 1.3, 0.8, 0.8 Hz, 1H), 7.43 (ddd, J = 8.1, 1.5, 0.8 Hz, 1H), 7.32 – 7.26 (m, 1H), 7.26 – 7.16 
(m, 3H), 7.14 (ddd, J = 8.0, 7.0, 1.0 Hz, 1H), 6.97 (d, J = 1.9 Hz, 1H); 13C NMR (125 MHz, 
CDCl3) δ 159.3 (d, JC-F= 246.4 Hz), 134.6 (d, JC-F = 501.8 Hz), 128.8 (d, JC-F = 8.8 Hz), 128.1, 
128.0 (d, JC-F = 4.1 Hz), 124.8 (d, JC-F = 3.2 Hz), 122.7, 120.6, 120.2, 119.9 (d, JC-F = 11.0 Hz), 
116.6, 116.4, 111.0, 101.6 (d, JC-F = 3.0 Hz); IR (NaCl/thin film): 3469, 3042, 2918, 2848, 1577, 
1472, 1460, 1212, 1178, 1109, 928 cm-1; HRMS (MM) calc’d for [M+H]+ 212.0870, found 
212.0869. 
 
Preparation of 2-(ethylphthalimide)indole (6v) 
I
NH2
NPhth
i.  Pd(PPh3)2Cl2, CuI, Et3N, 23 ºC
ii.  InBr3, PhMe, 110 ºC N
H
N
O
O(45% yield) 6vS6 S8  
 2-(ethylphthalimide)indole (1v) was prepared by an analogous procedure to that reported 
by Sakai et. al.8 A flame-dried flask was charged with 2-iodoaniline (S6, 500 mg, 2.30 mmol, 
1.00 equiv), 2-(but-3-yn-1-yl)isoindoline-1,3-dione (S8, 550  mg, 2.75 mmol, 1.20 equiv),                                                         8 Sakai, N.; Annaka, K.; Fujita, A.; Sato, A.; Konakahara, T. J. Org. Chem. 2008, 73, 4160. 
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Pd(PPh3)2Cl2 (32 mg, 0.05 mmol, 0.02 equiv), copper (I) iodide (4.5 mg, 0.025 mmol, 0.01 
equiv) and Et3N (8 mL).  The mixture was stirred overnight at room temperature, then filtered 
through a plug of silica, concentrated and redissolved in PhMe (10 mL).  InBr3 (40 mg, 0.1 
mmol, 0.05 equiv) was added in one portion and the mixture was heated to 110 ºC for 5 h, then 
cooled to room temperature, filtered through celite and concentrated.  The crude residue was 
purified by silica gel chromatography (60:40 EtOAc:hexanes) to yield 302 mg (45% yield) of  2-
(ethylphthalimide)indole (6v) as a light yellow solid. 1H NMR (500 MHz, CDCl3) δ 8.26 (br s, 
1H), 7.83 (dd, J = 5.5, 3.1 Hz, 2H), 7.71 (dd, J = 5.5, 3.1 Hz, 2H), 7.51 (d, J = 7.8 Hz, 1H), 7.33 
(d, J = 8.1 Hz, 1H), 7.13 (ddd, J = 8.2, 7.1, 1.2 Hz, 1H), 7.06 (ddd, J = 7.5, 7.5, 1.0 Hz, 1H), 6.33 
(d, J = 1.2 Hz, 1H), 4.06 (t, J = 7.5 Hz, 2H), 3.21 (t, J = 7.4 Hz, 2H); 13C NMR (125 MHz, 
CDCl3) δ 168.3, 136.1, 134.9, 134.1, 131.9, 128.6, 123.4, 121.4, 120.0, 119.7, 110.6, 101.1, 37.1, 
27.4.; IR (NaCl/thin film): 3366, 1772, 1707, 1653, 1617, 1466, 1395, 1363, 1293 cm-1; HRMS 
(MM) calc’d for [M+H]+ 291.1128, found 291.1138. 
 
3. Optimization of Reaction Parameters. 
 
a. General Procedure 1 
 
An oven-dried vial was charged with 2-phenylindole (6a, 0.20 mmol, 1.00 equiv), the acrylate 
(0.24 mmol, 1.20 equiv) and an (R)-BINOL derivative and pumped into a glove box. The vial 
was charged with solvent to an indole concentration of 0.12 M, and SnCl4 (1.00 equiv, as a 1.0 
M solution in DCM) was added. The reaction was stirred at 20 °C for 2 hours, after which time it 
was removed from the glove box and quenched by dilution with 1 M HCl (5 mL) and MeCN (1 
mL). The aqueous layer was extracted with EtOAc (2 x 5 mL) and the combined organic layers 
were washed with saturated aqueous NaHCO3 (5 mL), dried (Na2SO4), filtered, and concentrated. 
The crude residue was purified by silica gel chromatography. 
 
Additive screens.  Reactions were performed following General Procedure 1 using 0.20 equiv 
(R)-BINOL. After the vial was pumped into the glove box, one of the following additives was 
added:  
• flame-dried powdered 4Å molecular sieves (200 wt % relative to indole)  
• K2CO3 (1.00 equiv)  
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• 2,6-lutidine (1.00 equiv) 
Upon addition of the additive, DCM was added to an indole concentration of 0.12 M and the 
reaction was further conducted as described above. 
 
Catalyst screens. Reactions were performed following General Procedure 1 using flame-dried 
powdered 4Å molecular sieves (200 wt % relative to indole) as an additive and DCM as a 
solvent. 
 
 
b. Characterization Data 
 
(S)-Nα-Trifluoroacetyl-2-phenyltryptophan benzyl ester (7a) 
Prepared from benzyl 2-trifluoroacetamidoacrylate9 (2a, 65.5 mg, 0.24 
mmol) following General Procedure 1. The crude residue was purified by 
silica gel chromatography (30:70 to 70:30 DCM:hexanes) to yield 11.1 
mg (12% yield) of 7a as a yellow solid.  The enantiomeric excess was 
determined to be 35% by chiral SFC analysis (OB-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 
nm): tR(major) = 11.0 min, tR(minor) = 12.9 min.  1H NMR (500 MHz, CDCl3) δ 8.14 (br s, 1H), 
7.57 (ddd, J = 7.9, 1.8, 0.7 Hz, 1H), 7.54 – 7.50 (m, 2H), 7.50 – 7.45 (m, 2H), 7.42 – 7.36 (m, 
2H), 7.34 – 7.29 (m, 3H), 7.24 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.16 (ddd, J = 8.0, 7.1, 1.0 Hz, 
1H), 7.11 – 7.07 (m, 2H), 6.67 (br d, J = 7.6 Hz, 1H), 4.95 (d, J = 12.2 Hz, 1H), 4.88 (dt, J = 7.8, 
6.0 Hz, 1H), 4.53 (d, J = 12.2 Hz, 1H), 3.65 – 3.56 (m, 2H); 13C NMR (125 MHz, CDCl3) δ 13C 
NMR (125 MHz, CDCl3) δ 170.1, 156.6 (q, JC-F = 37.8 Hz), 136.3, 135.6, 134.6, 132.4, 129.2, 
128.9, 128.5, 128.44, 128.38, 128.2, 128.1, 122.8, 120.3, 118.6, 115.3 (q, JC-F = 287.9 Hz), 
111.0, 105.6, 67.5, 53.3, 26.7; IR (NaCl/thin film): 3391, 3061, 2924, 1714, 1542, 1457, 1210, 
1173 cm-1; [α]D25 = +3.5 (c = 0.44, CHCl3). HRMS (MM) calc’d for [M+H]+ 467.1577, found 
467.1580. 
 
                                                        9  Synthesis of benzyl 2-trifluoroacetamidoacrylate (2a): Crossley, M.; Stamford, A. Aust. J. Chem. 1994, 
47, 1695. 
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(S)-Nα-Trifluoroacetyl-2-phenyltryptophan methyl ester (7b) 
Prepared from methyl 2-trifluoroacetamidoacrylate10 (2b, 47.3 mg, 0.24 
mmol) following General Procedure 1. The crude residue was purified by 
silica gel chromatography (0:100 to 5:95 EtOAc:toluene, then 0:100 to 
20:80 EtOAc:hexanes) to yield 9.0 mg (12% yield) of 7b as a yellow 
solid.  The enantiomeric excess was determined to be 42% by chiral SFC analysis (AS-H, 2.5 
mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 8.7 min, tR(minor) = 7.7 min. 1H NMR (500 
MHz, CDCl3) δ  8.17 (br s, 1H), 7.58 – 7.52 (m, 3H), 7.52 – 7.47 (m, 2H), 7.43 – 7.39 (m, 1H), 
7.38 (ddd, J = 8.1, 0.9, 0.9 Hz, 1H), 7.23 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.16 (ddd, J = 8.0, 7.0, 
1.0 Hz, 1H), 6.65 (br d, J = 7.3 Hz, 1H), 4.83 (dt, J = 7.8, 5.6 Hz, 1H), 3.66 – 3.56 (m, 2H), 3.34 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 170.5, 156.6 (q, JC-F = 37.7 Hz), 136.3, 135.6, 132.5, 
129.2, 129.0, 128.4, 128.2, 122.8, 120.3, 118.5, 115.3 (q, J C-F= 287.7 Hz), 111.0, 105.5, 53.2, 
52.5, 26.4; IR (NaCl/thin film): 3391, 3057, 2917, 2849, 1718, 1542, 1458, 1449, 1211, 1170 
cm-1 ; [α]D25 = +22.3 (c = 0.39, CHCl3). HRMS (MM) calc’d for [M+H]+ 391.1264, found 
391.1267. 
 
 
                                                        10 Synthesis of methyl 2-trifluoroacetamidocacrylate (2b): Navarre, L.; Martinez, R.; Genet, J.; Darses, S.  
J. Am. Chem. Soc. 2008, 130,  6159. 
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3. Optimized Conjugate Addition/Asymmetric Protonation. 
a. General Procedure 2 
An oven-dried vial was charged with the indole (1.00 equiv), methyl 2-acetamidoacrylate (2c, 
1.20 equiv)11 and (R)-3,3’-dibromo-BINOL (9f, 0.20 equiv) and pumped into a glove box. To the 
vial was added flame-dried powdered 4Å molecular sieves (200 wt % relative to indole). The 
vial was charged with DCM to an indole concentration of 0.12 M, and SnCl4 (1.00 equiv unless 
specifically indicated, as a 1 M solution in DCM) was added. The reaction was stirred at 20 °C 
for 2 hours, after which time it was removed from the glove box and quenched by dilution with 1 
M HCl (5 mL) and MeCN (1 mL). The aqueous layer was extracted with EtOAc (2 x 5 mL) and 
the combined organic layers were washed with saturated aqueous NaHCO3 (5 mL), dried 
(Na2SO4), filtered, and concentrated. The crude residue was purified by silica gel 
chromatography. 
 
b. Characterization Data 
 (S)-Nα-Acetyl-2-phenyltryptophan methyl ester (7c) 
Prepared from 2-phenylindole (6a, 19.0 mg, 0.10 mmol) following 
General Procedure 2.  The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 25.6 mg (76% 
yield) of 7c as a white foam.  The enantiomeric excess was determined to 
be 93% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm).  tR(major) = 
5.7 min, tR(minor) = 6.9 min. [α]D25 = +37.7 (c = 0.94, CHCl3).  Spectral data matches that 
reported in the literature.12 
 
(S)-Nα-Acetyl-1-methyl-2-phenyltryptophan methyl ester (7d)  
Prepared from 1-methyl-2-phenylindole (6b, 41.4 mg, 0.20 mmol) 
following General Procedure 2.  The crude residue was purified by silica 
gel chromatography (0:100 to 55:45 EtOAc:hexanes) to yield 43.4 mg 
(63% yield) of 7d as a yellow solid.  The enantiomeric excess was                                                         11 Methyl 2-acetamidoacrylate (2c) is commercially available, or can be prepared according to Crestey, 
F.; Collot, V.; Steibing, S.; Rault, S. Synthesis 2006, 20, 3506. 12 Angelini, E.; Balsamini, C.; Bartoccini, F.; Lucarini, S.; Piersanti, G. J. Org. Chem. 2008, 73, 5654. 
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determined to be 85% by chiral SFC analysis (AD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 
nm): tR(major) = 4.6 min, tR(minor) = 3.9 min.  1H NMR (500 MHz, CDCl3) δ 7.60 (ddd, J = 7.9, 
1.2, 0.7 Hz, 1H), 7.56 – 7.49 (m, 2H), 7.48 – 7.44 (m, 1H), 7.42 – 7.38 (m, 2H), 7.34 (ddd, J = 
8.2, 0.9, 0.9 Hz, 1H), 7.26 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 
5.72 (br d, J = 7.8 Hz, 1H), 4.74 (dt, J = 8.0, 5.6 Hz, 1H), 3.57 (s, 3H), 3.39 (s, 3H), 3.41 (dd, J = 
14.7, 5.7 Hz, 1H), 3.34 (dd, J=14.8, 5.6 Hz, 1H), 1.73 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.2, 169.5, 139.2, 136.9, 131.6, 130.7, 128.7, 128.4, 127.9, 122.0, 119.7, 118.7, 109.5, 106.7, 
52.8, 52.0, 30.8, 26.6, 23.0.;  IR (NaCl/thin film): 3288, 3055, 2950, 1743, 1657, 1539, 1469, 
1441, 1368, 1238, 1212 cm-1; [α]D25 = +21.3 (c = 0.91, CHCl3). HRMS (MM) calc’d for [M+H]+ 
351.1703, found 351.1708. 
 
(S)-Nα-Acetyl-1-allyl-2-phenyltryptophan methyl ester (7e) 
Prepared from 1-allyl-2-phenylindole (6c, 46.6 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (0:100 to 55:45 EtOAc:hexanes) to yield 51.3 mg (68% 
yield) of 7e as a yellow foam. The enantiomeric excess was determined to 
be 85% by chiral SFC analysis (AS-H, 2.5 mL/min, 30% IPA in CO2, λ = 
254 nm): tR(major) = 2.9 min, tR(minor) = 2.4 min. 1H NMR (500 MHz, CDCl3) δ 7.62 (ddd, J = 
7.8, 1.0, 1.0 Hz, 1H), 7.53 – 7.47 (m, 2H), 7.47 – 7.42 (m, 1H), 7.42 – 7.37 (m, 2H), 7.30 (ddd, J 
= 8.1, 0.9, 0.9 Hz, 1H), 7.23 (ddd, J = 8.2, 7.0, 1.2 Hz, 1H), 7.17 (ddd, J = 8.0, 7.0, 1.1 Hz, 1H), 
5.85 (ddt, J = 17.1, 10.3, 4.7 Hz, 1H), 5.76 (br d, J = 7.9 Hz, 1H), 5.11 (dtd, J = 10.4, 1.7, 1.2 
Hz, 1H), 4.82 (dtd, J = 17.1, 1.9, 1.3 Hz, 1H), 4.76 (dt, J = 8.0, 5.8 Hz, 1H), 4.56 (dt, J = 4.7, 1.8 
Hz, 2H), 3.39 (s, 3H), 3.36 (dd, J = 14.7, 5.7 Hz, 1H), 3.29 (dd, J = 14.7, 5.9 Hz, 1H), 1.75 (s, 
3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.5, 139.0, 136.3, 133.5, 131.5, 130.5, 128.7, 
128.5, 128.1, 122.0, 119.8, 118.8, 116.3, 110.2, 107.2, 52.8, 52.0, 46.3, 26.8, 23.0; IR (NaCl/thin 
film): 3435, 3287, 3056, 2950, 2926, 2851, 1744, 1658, 1538, 1500, 1408, 1367, 1219, 1196, 
1134; [α]D25 = +13.8 (c = 2.96, CHCl3). HRMS (MM) calc’d for [M+H]+ 377.1860, found 
377.1865. 
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(S)-Nα-Acetyl-4-methyl-2-phenyltryptophan methyl ester (7f) 
Prepared from 4-methyl-2-phenylindole13 (6d, 21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 30.8 mg 
(88% yield) of 7f as a white foam. The enantiomeric excess was 
determined to be 96% by chiral SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 
nm): tR(major) = 9.9 min, tR(minor) = 8.9 min. 1H NMR (500 MHz, CDCl3) δ 8.32 (br s, 1H), 
7.55 – 7.45 (m, 4H), 7.44 – 7.37 (m, 1H), 7.19 (d, J = 8.0 Hz, 1H), 7.08 (m, 1H), 6.91 (m, 1H), 
5.44 (br d, J = 7.6 Hz, 1H), 4.63 (td, J = 8.2, 5.0 Hz, 1H), 3.69 – 3.45 (m, 2H), 3.44 (s, 3H), 2.78 
(s, 3H), 1.64 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.3, 169.7, 136.3, 136.1, 133.1, 130.5, 
129.2, 128.9, 128.3, 126.9, 122.5, 122.3, 109.0, 107.6, 54.2, 52.1, 27.6, 22.8, 20.5; IR (NaCl/thin 
film): 3295, 3052, 2952, 1741, 1659, 1602, 1547, 1514, 1492, 1449, 1372, 1218; [α]D25 = -29.0 
(c = 0.63, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 351.1698. 
 
(S)-Nα-Acetyl-5-methyl-2-phenyltryptophan methyl ester (7g) 
Prepared from 5-methyl-2-phenylindole8 (6e, 42.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 
58.0 mg (83% yield) of 7g as a white foam. The enantiomeric excess 
was determined to be 95% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 
nm): tR(major) = 4.9 min, tR(minor) = 6.4 min. 1H NMR (500 MHz, CDCl3) δ 8.12 (br s, 1H), 
7.54 (ddd, J = 10.1, 6.1, 4.2 Hz, 2H), 7.50 – 7.43 (m, 2H), 7.40 – 7.33 (m, 2H), 7.24 (d, J = 8.3 
Hz, 1H), 7.06 – 7.00 (m, 1H), 5.78 (br d, J = 8.1 Hz, 1H), 4.83 (dt, J = 8.1, 5.4 Hz, 1H), 3.53 – 
3.51 (m, 2H), 3.31 (s, 3H), 2.46 (s, 3H), 1.66 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.1, 
169.5, 136.1, 134.0, 133.3, 129.7, 129.2, 129.1, 128.2, 128.0, 124.1, 118.6, 110.6, 106.3, 52.7, 
51.2, 26.5, 22.8, 21.5; IR (NaCl/thin film): 3379, 3365, 2948, 1737, 1658, 1439, 1372, 1306, 
1217 cm-1; [α]D25 = +33.8 (c = 0.26, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 
351.1680. 
 
                                                        13 Zhao, J.; Zhang, Y.; Cheng, K. J. Org. Chem. 2008, 73, 7428.   
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(S)-Nα-Acetyl-6-methyl-2-phenyltryptophan methyl ester (7h) 
Prepared from 6-methyl-2-phenylindole13 (6f, 21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield  
27.9 mg (80% yield) of 7h as a colorless oil. The enantiomeric 
excesses was determined to be 89% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in 
CO2, λ = 254 nm): tR(major) = 9.1 min, tR(minor) = 10.1 min. 1H NMR (500 MHz, CDCl3) δ 
8.01 (br s, 1H), 7.55 (ddd, J = 5.8, 4.0, 2.1 Hz, 2H), 7.48 – 7.44 (m, 3H), 7.39 – 7.33 (m, 1H), 
7.14 (s, 1H), 6.97 (dd, J = 8.3, 1.5 Hz, 1H), 5.78 (br d, J = 7.8 Hz, 1H), 4.83 (dt, J = 8.0, 5.4 Hz, 
1H), 3.55 – 3.49 (m, 2H), 3.30 (s, 3H), 2.47 (s, 3H), 1.67 (s, 3H); 13C NMR (125 MHz, CDCl3) 
172.1, 169.6, 136.1, 135.2, 133.3, 132.4, 129.1, 128.2, 127.9, 127.3, 121.8, 118.5, 110.9, 106.5, 
52.7, 52.0, 26.6, 22.9, 21.7; IR (NaCl/thin film): 3292, 3052, 2958, 2908, 1741, 1658, 1545, 
1530, 1511, 1446, 1375, 1216; [α]D25 = +39.3 (c = 0.38, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 351.1703, found 351.1698. 
 
(S)-Nα-Acetyl-7-methyl-2-phenyltryptophan methyl ester (7i) 
Prepared from 7-methyl-2-phenylindole13 (6g, 21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 33.0 mg 
(94% yield) of 7i as a white foam. The enantiomeric excess was 
determined to be 94% by chiral SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 
nm): tR(major) = 5.6 min, tR(minor) = 5.0 min. 1H NMR (500 MHz, CDCl3) δ 8.23 (br s, 1H), 
7.61 – 7.54 (m, 2H), 7.51 – 7.45 (m, 2H), 7.42 (d, J = 8.1 Hz, 1H), 7.40 – 7.35 (m, 1H), 7.11 – 
7.04 (m, 1H), 7.03 – 6.97 (m, 1H), 5.79 (br d, J = 8.1 Hz, 1H),  4.82 (dt, J  = 8.1, 5.7 Hz, 1H), 
2.55 (dd, J = 12.5, 3.1 Hz, 1H), 3.51 (dd, J = 12.5, 3.1 Hz, 1H), 3.30 (s, 3H), 2.50 (s, 3H), 1.65 
(s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.1, 169.6, 135.8, 135.3, 133.3, 129.1, 128.9, 128.4, 
128.0, 123.1, 120.20, 120.18, 116.5, 107.1, 52.7, 51.9, 26.6, 22.8, 16.6; IR (NaCl/thin film): 
3283, 3053, 2950, 1736, 1659, 1518, 1438, 1372, 1306, 1266, 1219, 1137, 1043; [α]D25 = +26.5 
(c = 0.20, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 351.1708. 
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(S)-Nα-Acetyl-5-methoxy-2-phenyltryptophan methyl ester (7j) 
Prepared from 5-methoxy-2-phenylindole13 (6h, 45.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 
62.0 mg (85% yield) of 7j as a colorless oil. The enantiomeric excess 
was determined to be 91% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 
nm): tR(major) = 4.7 min, tR(minor) = 6.5 min. 1H NMR (500 MHz, CDCl3) δ 8.24 (br s, 1H), 
7.58 – 7.49 (m, 2H), 7.50 – 7.41 (m, 2H), 7.36 (dd, J = 7.4, 7.4 Hz, 1H), 7.24 (d, J = 8.7 Hz, 1H), 
7.05 (d, J = 2.3 Hz, 1H), 6.90 – 6.80 (m, 1H), 5.82 (br d, J = 7.9 Hz, 1H), 4.82 (td, J = 7.9, 5.4 
Hz, 1H), 3.87 (s, 3H), 3.49 (m, 2H), 3.29 (s, 3H), 1.67 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.2, 169.6, 154.4, 136.7, 133.2, 130.8, 129.8, 129.1, 128.2, 128.0, 112.7, 111.7, 106.5, 100.5, 
55.9, 52.7, 52.0, 26.6, 22.9; IR (NaCl/thin film): 3291, 3057, 2926, 1739, 1652, 1558, 1539, 
1520, 1483, 1455, 1374, 1218, 1178; [α]D25 = +32.6 (c = 0.93, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 367.1652, found 367.1658. 
 
(S)-Nα-Acetyl-5-bromo-2-phenyltryptophan methyl ester (7k) 
Prepared from 5-bromo-2-phenylindole14 (6i, 54.0 mg, 0.20 mmol) 
with 1.6 equiv SnCl4 following General Procedure 2. The crude residue 
was purified by silica gel chromatography (30:70 to 100:0 
EtOAc:hexanes) to yield 49.5 mg (60% yield) of 7k as a white foam. 
The enantiomeric excess was determined to be 93% by chiral SFC analysis (AD-H, 2.5 mL/min, 
30% IPA in CO2, λ = 254 nm): tR(major) = 5.3 min, tR(minor) = 7.9 min. 1H NMR (500 MHz, 
CDCl3) δ 8.42 (br s, 1H), 7.66 (d, J = 2.0 Hz, 1H), 7.56 – 7.50 (m, 2H), 7.49 – 7.43 (m, 2H), 7.42 
– 7.34 (m, 1H), 7.28 – 7.24 (m, 1H), 7.22 – 7.18 (m, 1H), 5.75 (br d, J = 8.1 Hz, 1H), 4.82 (dt, J 
= 8.1, 5.7 Hz, 1H), 3.53 (dd, J = 14.9, 5.5 Hz, 1H), 3.46 (dd, J = 14.9, 4.8 Hz, 1H), 3.36 (s, 3H), 
1.63 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 171.9, 169.6, 137.2, 134.2, 132.6, 131.1, 129.2, 
128.3, 128.2, 125.2, 121.6, 113.1, 112.4, 106.4, 52.6, 52.1, 26.5, 22.8; IR (NaCl/thin film): 3417, 
3369, 3282, 1734, 1654, 1521, 1466, 1437, 1374, 1215; [α]D25 = +47.2 (c = 1.04, CHCl3).                                                         14 Prepared from 4-bromo-2-iodoaniline by an analogous procedure to that reported by Sakai et. al. 
(reference 8). Spectral data matches that reported in the literature: Homes, T. P.; Mattner, F.; Keller, P. 
A.; Katsifis, A. Bioorg. Med. Chem. 2006, 14, 3938. 
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HRMS (MM) calc’d for [M+H]+ 415.0652, found 415.0653. 
 
(S)-Nα-Acetyl-5-fluoro-2-phenyltryptophan methyl ester (7l) 
Prepared from 5-fluoro-2-phenylindole13 (6j, 42.0 mg, 0.20 mmol) with 
1.6 equiv SnCl4 following General Procedure 2. The crude residue was 
purified by silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) 
to yield 44.7 mg (63% yield) of 7l as a colorless oil. The enantiomeric 
excess was determined to be 92% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, 
λ = 254 nm): tR(major) = 3.8 min, tR(minor) = 5.2 min. 1H NMR (500 MHz, CDCl3) δ 8.30 (br s, 
1H), 7.60 – 7.52 (m, 2H), 7.50 – 7.43 (m, 2H), 7.42 – 7.34 (m, 1H), 7.27 – 7.24 (m, 1H), 7.21 
(dd, J = 9.8, 2.6 Hz, 1H), 6.94 (ddd, J = 9.0, 9.0, 2.6 Hz, 1H), 5.77 (br d, J = 7.8 Hz, 1H), 4.82 
(dt, J = 8.1, 5.4 Hz, 1H), 3.53 (dd, J = 14.9, 5.6 Hz, 1H), 3.47 (dd, J = 14.9, 5.0 Hz, 1H), 3.35 (s, 
3H), 1.64 (s, 2H); 13C NMR (125 MHz, CDCl3) δ 172.7, 169.8, 168.3, 135.6, 134.2, 132.5, 
131.9, 128.6, 123.5, 121.8, 119.7, 118.2, 110.8, 107.4, 52.9, 52.4, 37.0, 27.0, 25.3, 23.1; IR 
(NaCl/thin film): 3275, 3062, 2952, 1733, 1652, 1584, 1558, 1539, 1520, 1486, 1456, 1436, 
1374, 1266, 1217, 1180; [α]D25 = +49.9 (c = 1.25, CHCl3). HRMS (MM) calc’d for [M+H]+ 
355.1452, found 355.1455. 
 
(S)-Nα-Acetyl-2-(4-methylphenyl)tryptophan methyl ester (7m) 
Prepared from 2-(4-methylphenyl)indole15 (6k, 41.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 60.1 mg 
(86% yield) of 7m as a white foam. The enantiomeric excess was 
determined to be 94% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 
nm).  tR(major) = 6.6 min, tR(minor) = 8.8 min. 1H NMR (500 MHz, CDCl3) δ 8.20 (br s, 1H), 
7.56 (d, J = 8.1 Hz, 1H), 7.45 (d, J = 8.1, 2H), 7.34 (d, J = 8.1, 1H), 7.28 (d, J = 8.1, 2H), 7.19 
(ddd, J = 7.8, 7.1, 1.2 Hz, 1H), 7.15 – 7.09 (m, 1H), 5.77 (br d, J = 8.1, 1H), 4.82 (dt, J = 7.8, 5.5 
Hz, 1H), 3.54 (dd, J = 13.1, 4.0 Hz, 1H), 3.50 (dd, J = 13.1, 3.7 Hz, 1H), 3.33 (s, 3H), 2.40 (s, 
                                                        15 Prepared from 2-iodoaniline by an analogous procedure to that reported by Sakai et. al. (reference 8). 
Spectral data matches that reported in the literature: Shen, M.; Leslie, B. E.; Driver, T. G. Angew. Chem., 
Int. Ed. 2008, 47, 5056. 
N
H
Ph
CO2Me
NHAc
F
N
H
CO2Me
NHAc
Me
  S19 
3H), 1.66 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.6, 138.0, 136.1, 135.6, 130.2, 
129.8, 129.4, 128.1, 122.3, 119.9, 118.7, 110.9, 106.4, 52.8, 52.0, 26.6, 22.8, 21.2; IR (NaCl/thin 
film): 3365, 3271, 3052, 2951, 1737, 1657, 1519, 1460, 1439, 1375, 1305, 1217 cm-1; [α]D25 =  
43.2 (c = 0.74, CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 351.1700. 
 
(S)-Nα-Acetyl-2-(2-methylphenyl)tryptophan methyl ester (7n) 
Prepared from 2-(2-methylphenyl)indole16 (6l, 21.0 mg, 0.1 mmol) 
following General Procedure 2.  The crude residue was purified by flash 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 9.2 mg (26% 
yield) of 7n. The enantiomeric excess was determined to be 87% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): 
tR(major) = 4.3 min, tR(minor) = 4.9 min. 1H NMR (500 MHz, CDCl3) δ 8.03 (br s, 1H), 7.62 – 
7.55 (dd, J = 7.6, 0.9 Hz, 1H), 7.38 – 7.32 (m, 4H), 7.31 – 7.27 (m, 1H), 7.22 (ddd, J = 8.1, 5.6, 
2.1 Hz, 1H), 7.16 (ddd, J = 7.1, 5.6, 1.1 Hz, 1H), 5.71 (br d, J = 7.9 Hz, 1H), 4.82 – 4.68 (dt, J = 
7.9, 5.4 Hz, 1H), 3.38 – 3.29 (m, 4H), 3.28 – 3.16 (m, 1H), 2.28 (s, 3H), 1.73 (s, 3H); 13C NMR 
(125 MHz, CDCl3) δ 172.1, 169.6, 137.3, 135.8, 135.5, 132.1, 130.9, 130.8, 128.9, 128.7, 126.0, 
122.3, 119.9, 118.8, 110.8, 107.6, 52.8, 52.0, 26.6, 23.0, 20.0; IR (NaCl/thin film): 3385, 3271, 
3062, 2924, 2853, 1734, 1653, 1559, 1539, 1521, 1457, 1437, 1374; [α]D25 = +21.5 (c = 0.29, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 351.1703, found 351.1709. 
 
(S)-Nα-Acetyl-2-(4-chlorophenyl)tryptophan methyl ester (7o) 
Prepared from 2-(4-chlorophenyl)indole13 (6m, 45.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 55.2 mg 
(75% yield) of 7o as a colorless oil. The enantiomeric excess was 
determined to be 93% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 
nm): tR(major) = 6.1 min, tR(minor) = 7.0 min. 1H NMR (500 MHz, CDCl3) δ 8.45 (br s, 1H), 
7.56 (d, J = 8.1 Hz, 1H), 7.49 – 7.43 (m, 2H), 7.43 – 7.37 (m, 2H), 7.33 (ddd, J  = 8.1, 8.1, 1.0                                                         16 Prepared from 2-iodoaniline by an analogous procedure to that reported by Sakai et. al. (reference 8). 
Spectral data matches that reported in the literature: Zhao, J.; Zhang, Y.; Cheng, K. J. Org. Chem. 2008, 
73, 7428. 
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Hz, 1H), 7.23 – 7.18 (m, 1H), 7.14 (ddd, J = 8.0, 7.1, 1.1 Hz, 1H), 5.85 (br d, J = 8.1 Hz, 1H), 
4.83 (dt, J = 8.1, 5.5 Hz, 1H), 3.55 – 3.38 (m, 2H), 3.34 (s, 3H), 1.69 (s, 3H); 13C NMR (125 
MHz, CDCl3) δ 172.1, 169.6, 135.8, 134.6, 133.9, 131.5, 129.4, 129.3, 122.7, 120.1, 118.9, 
111.1, 107.1, 52.8, 52.1, 29.6, 26.7, 22.9; IR (NaCl/thin film): 3280, 3058, 2948, 1737, 1657, 
1519, 1487, 1458, 1439, 1373, 1310, 1216, 1093 cm-1; [α]D25 = +40.8 (c = 0.96, CHCl3). HRMS 
(MM) calc’d for [M+H]+ 371.1157, found 371.1158. 
 
(S)-Nα-Acetyl-2-(4-fluorophenyl)tryptophan methyl ester (7p) 
Prepared from 2-(4-fluorophenyl)indole8 (6n, 42.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc/hexanes) to yield 55.6 mg 
(78% yield) of 7p as a colorless oil. The enantiomeric excess was 
determined to be 92% by chiral SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 
nm): tR(major) = 6.1 min, tR(minor) = 6.9 min. 1H NMR (500 MHz, CDCl3) δ  8.19 (d, J = 47.9 
Hz, 1H), 7.57 (dd, J = 7.9, 1.1 Hz, 1 H), 7.54 – 7.51 (m, 2H), 7.36 (ddd, J = 8.1, 8.1, 0.9 Hz, 
1H), 7.23 – 7.10 (m, 4H), 5.82 (d, J = 8.1 Hz, 1H), 4.83 (dt, J = 8.1, 5.5 Hz, 1H), 3.55 – 3.40 (m, 
2H), 3.34 (s, 3H), 1.71 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.2, 169.5, 135.6, 135.0, 130.1, 
130.1, 129.4, 122.7, 120.2, 118.9, 116.2, 116.1, 110.9, 106.9, 52.8, 52.0, 26.7, 22.9.; IR 
(NaCl/thin film): 3364, 3271, 3061, 2925, 2853, 1738, 1661, 1553, 1505, 1460, 1440, 1373, 
1221, 1158; [α]D25 = +38.2 (c = 0.65, CHCl3). HRMS (MM) calc’d for [M+H]+ 355.1452, found 
355.1460. 
 
(S)-Nα-Acetyl-2-(3-fluorophenyl)tryptophan methyl ester (7q) 
Prepared from 2-(3-fluorophenyl)indole15 (6o, 42.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 ethyl acetate/hexanes) to yield 50.6 
mg (76% yield) of 7q as a white foam. The enantiomeric excess was 
determined to be 92% by chiral SFC analysis (AD-H, 2.5 mL/min, 30% 
IPA in CO2, λ = 254 nm): tR(major) = 3.8 min, tR(minor) = 4.6 min. 1H NMR (500 MHz, CDCl3) 
δ 8.65 (br s, 1H), 7.57 (d, J = 8.1 Hz, 1H), 7.41 – 7.37 (m, 1H), 7.33-7.31 (m, 2H), 7.27-7.24 (m, 
1H), 7.19 (ddd, J = 8.2, 7.0, 1.0 Hz, 1H), 7.13 (ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 7.07 – 7.03 (m, 
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1H), 5.89 (br d, J = 8.1 Hz, 1H), 4.84 (dt, J = 8.1, 5.5 Hz, 1H), 3.53 (dd, J = 13.6, 4.7 Hz, 1H), 
3.49 (dd, J = 13.6, 4.2 Hz, 1H), 3.34 (s, 3H), 1.69 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.1, 
169.7, 162.9 (d, JC-F = 246.3 Hz), 135.8, 135.2 (d, JC-F = 7.5 Hz), 134.5 (d, JC-F = 2.5 Hz), 130.6 
(d, JC-F = 8.8 Hz), 129.2, 123.9 (d, JC-F = 3.8 Hz), 122.8, 120.0, 118.9, 115.1 (d, JC-F = 21.2 Hz), 
114.7 (d, JC-F = 21.2 Hz), 111.1, 107.3, 52.8, 52.0, 26.7, 22.8; IR (NaCl/thin film): 3370, 3275, 
3060, 2952, 1735, 1655, 1614, 1585, 1522, 1438, 1374, 1266, 1200, 1155 cm-1; [α]D25 = +37.6 (c 
= 1.21, CHCl3). HRMS (MM) calc’d for [M+H]+ 355.1452, found 355.1450. 
 
(S)-Nα-Acetyl-2-(2-fluorophenyl)tryptophan methyl ester (7r) 
Prepared from 2-(2-fluorophenyl)indole (6p, 21.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 12.4 mg 
(35% yield) of 7r. The enantiomeric excesses was determined to be 92% 
by chiral SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 9.5 min, 
tR(minor) = 8.4 min. 1H NMR (500 MHz, CDCl3) δ 8.28 (s, 1H), 7.61 (d, J = 7.9 Hz, 1H), 7.55 
(ddd, J = 7.5, 7.5, 1.8 Hz, 1H), 7.45 – 7.35 (m, 2H), 7.29 (ddd, J = 7.5, 7.5, 1.2 Hz, 1H), 7.25 – 
7.20 (m, 1H), 7.19 – 7.10 (m, 1H), 5.83 (br d, J = 7.6 Hz, 1H), 4.85 (dt, J = 7.9, 5.5 Hz, 1H), 3.55 
– 3.39 (m, 2H), 3.36 (s, 2H), 1.73 (s, 3H).; 13C NMR (125 MHz, CDCl3) δ 172.2, 169.5, 159.8 
(d, JC-F = 246.3 Hz), 135.9, 131.4 (d, JC-F = 3.8 Hz) 130.2 (d, JC-F = 8.8 Hz), 129.73, 128.65, 
124.8 (d, JC-F = 3.8 Hz), 122.84, 120.6 (d, JC-F = 15.0 Hz), 120.0, 119.0, 116.4 (d, JC-F = 21.3 
Hz), 111.0, 108.8, 52.5, 52.0, 26.8, 26.8, 22.9; IR (NaCl/thin film): 3275, 3058, 2925, 2853, 
1734, 1653, 1523, 1490, 1457, 1437, 1374, 1245, 1216, 1130, 1104; [α]D25 = +39.8 (c = 0.41, 
CHCl3). HRMS (MM) calc’d for [M+H]+ 355.1452, found 355.1463. 
 
(S)-Nα-Acetyl-2-(3-methoxyphenyl)tryptophan methyl ester (7s) 
Prepared from 2-(3-methoxyphenyl)indole17 (6q, 45.0 mg, 0.20 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (30:70 to 100:0 EtOAc:hexanes) to yield 65.0 mg 
                                                        17 Prepared from 2-iodoaniline by an analogous procedure to that reported by Sakai et. al. (reference 8).  
Spectral data matches that reported in the literature: Yang, S.-D.; Sun, C. L.;  Fang, Z.; Li, B.-J.; Li, Y.-
Z.; Shi, Z.-J. Angew. Chem., Int. Ed. 2008, 47, 1473. 
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(88% yield) of 7s as a colorless oil. The enantiomeric excess was determined to be 92% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm): tR(major) = 5.9 min, tR(minor) 
= 7.6 min. 1H NMR (500 MHz, CDCl3) δ 8.40 (br s, 1H), 7.55 (d, J = 8.1 Hz, 1H), 7.40 – 7.31 
(m, 2H), 7.19 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.16 – 7.10 (m, 2H), 7.08 (dd, J = 2.6, 1.6 Hz, 1H), 
6.91 (ddd, J = 8.3, 2.6, 0.8 Hz, 1H), 5.82 (br  d, J = 7.8 Hz, 1H), 4.83 (dt, J = 7.8, 5.5 Hz, 1H), 
3.85 (s, 3H), 3.57 – 3.49 (m, 2H), 3.35 (s, 3H), 1.65 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.2, 169.6, 160.0, 135.8, 135.6, 134.4, 130.2, 129.3, 122.5, 120.6, 119.9, 118.8, 113.8, 113.5, 
111.0, 106.7, 55.4, 52.8, 52.0, 26.6, 22.8; IR (NaCl/thin film): 3282, 3058, 2951, 1738, 1658, 
1603, 1520, 1462, 1439, 1373, 1218, 1040; [α]D25 = +40.3 (c = 1.16, CHCl3). HRMS (MM) 
calc’d for [M+H]+ 367.1652, found 367.1656. 
 
(S)-Nα-Acetyl-2-methyltryptophan methyl ester (7t) 
Prepared from 2-methylindole (6r, 26.0 mg, 0.20 mmol) following 
General Procedure 2.  The crude residue was purified by silica gel 
chromatography (50:50 to 100:0 EtOAc:hexanes) to yield 31.0 mg (61% 
yield) of 7t as a white foam.  The enantiomeric excess was determined to 
be 85% by chiral SFC analysis (AD-H, 2.5 mL/min, 25% IPA in CO2, λ = 254 nm): tR(major) = 
3.9 min, tR(minor) = 2.7 min. [α]D25 = +25.9 (c = 0.99, CHCl3).  Spectral data matches that 
reported in the literature.9 
 
(S)-Nα-Acetyl-2-butyltryptophan methyl ester (7u) 
Prepared from 2-butylindole18 (6s, 35.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 45.8 mg (72% 
yield) of 7u as a colorless oil. The enantiomeric excess was determined to 
be 91% by chiral SFC analysis (AD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 
5.1 min, tR(minor) = 4.2 min. 1H NMR (500 MHz, CDCl3) δ 8.03 (br s, 1H), 7.46 – 7.40 (m, 1H), 
7.31 – 7.24 (m, 1H), 7.15 – 6.99 (m, 2H), 6.00 (br d, J = 7.8 Hz, 1H), 4.88 (dt, J = 8.1, 5.7 Hz,                                                         18 Prepared from 2-iodoaniline by an analogous procedure to that reported by Sakai et. al.  (reference 8).  
Spectral data matches that reported in the literature: Ambrogio, I.; Cacchi, S.; Fabrizi, G.; Prastaro, A. 
Tetrahedron 2009, 65, 8916. 
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1H), 3.65 (s, 3H), 3.26 (dd, J = 5.7, 0.9 Hz, 2H), 2.69 (td, J = 7.8 2.2 Hz, 2H), 1.93 (s, 3H), 1.66 
– 1.57 (m, 2H), 1.45 – 1.31 (m, 2H), 0.95 (t, J = 7.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.6, 169.6, 137.4, 135.2, 128.8, 121.3, 119.5, 117.9, 110.4, 105.26, 105.29, 53.0, 52.3, 31.8, 
26.8, 25.7, 23.2, 22.6, 13.9; IR (NaCl/thin film): 3296, 3058, 2955, 2871, 1737, 1658, 1562, 
1530, 1463, 1439, 1376, 1217, 1129; [α]D25 = +16.3 (c = 0.83, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 317.1860, found 317.1855. 
 
 
(S)-Nα-Acetyl-2-isopropyltryptophan methyl ester (7v) 
Prepared from 2-isopropylindole19 (6t, 32.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 39.6 mg (66% 
yield) of 7v as a colorless oil. The enantiomeric excess was determined to 
be 92% by chiral SFC analysis (AD-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm). tR(major) = 
6.4 min, tR(minor) = 5.6 min. 1H NMR (500 MHz, CDCl3) δ 8.16 (br s, 1H), 7.48 – 7.41 (m, 1H), 
7.30 – 7.27 (m, 1H), 7.15 – 7.02 (m, 2H), 6.04 (br d, J = 8.0 Hz, 1H), 4.89 (dt, J = 8.1, 5.7 Hz, 
1H), 3.66 (s, 3H), 3.29 (dd, J = 12.7, 4.0 Hz, 1H), 3.26 (dd, J = 12.7, 3.4 Hz, 1H), 3.18 (m, 1H), 
1.93 (s, 3H1.31 (d, J = 3.3 Hz, 3H), 1.30 (d, J = 3.3 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 
172.6, 169.7, 142.7, 135.2, 128.7, 121.3, 119.5, 117.9, 110.6, 103.6, 53.0, 52.3, 26.7, 25.3, 23.2, 
23.0; IR (NaCl/thin film): 3305, 2962, 1734, 1700, 1653, 1559, 1539, 1506, 1457, 1436, 1374, 
1299, 1217 cm-1; [α]D25 = +22.2 (c = 0.35, CHCl3). HRMS (MM) calc’d for [M+H]+ 303.1703, 
found 303.1709. 
 
(S)-Nα-Acetyl-2-(tert-butyl)tryptophan methyl ester (7w) 
Prepared from 2-(tert-butyl)indole13 (6u, 35.0 mg, 0.20 mmol) following 
General Procedure 2. The crude residue was purified by silica gel 
chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 18.1 mg (29% 
yield) of 7w as a yellow oil. The enantiomeric excess was determined to 
be 84% by chiral SFC analysis (OD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) =                                                         19 Prepared from 2-iodoaniline by an analogous procedure to that reported by Sakai et. Al (reference 8).  
Spectral data matches that reported in the literature: Smith, A. B.; Visnick, M.; Haseltine, J. N.; 
Sprengeler, P. A. Tetrahedron 2007, 42, 2957. 
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12.8 min, tR(minor) = 14.2 min. 1H NMR (500 MHz, CDCl3) δ 8.07 (br s, 1H), 7.47 (dd, J = 
14.0, 7.1 Hz, 1H), 7.27 (dd, J = 5.8, 4.8 Hz, 1H), 7.15 – 7.03 (m, 2H), 6.06 (br d, J = 7.4 Hz, 1H), 
4.84 (m, 1H), 3.54 (s, 3H), 3.38 – 3.29 (m, 2H), 1.86 (s, 3H), 1.49 (s, 9H); 13C NMR (125 MHz, 
CDCl3) δ 173.2, 169.6, 143.4, 133.9, 129.8, 121.3, 119.4, 117.7, 110.4, 104.3, 53.7, 52.2, 33.2, 
30.7, 28.6, 23.0; IR (NaCl/thin film): 3326, 3047, 2961, 2918, 2868, 1734, 1653, 1539, 1457, 
1436, 1374, 1303, 1254, 1211, 1128; [α]D25 = +12.4 (c = 0.36, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 317.1860, found 317.1856. 
 
(S)-Nα-Acetyl-2-(ethylphthalimide)tryptophan methyl ester (7x) 
Prepared from 2-(ethylphthalimide)indole (6v, 29.0 mg, 0.10 mmol) 
following General Procedure 2. The crude residue was purified by silica 
gel chromatography (70:30 to 100:0 EtOAc:hexanes) to yield 34.6 mg 
(80% yield) of 7x as a yellow foam. The enantiomeric excess was 
determined to be 90% by chiral SFC analysis (AD-H, 2.5 mL/min, 25% 
IPA in CO2, λ = 254 nm): tR(major) = 7.3 min, tR(minor) = 6.3 min. 1H NMR (500 MHz, CDCl3) 
δ 8.47 (br s, 1H), 7.83 (dd, J = 5.4, 2.9 Hz, 2H), 7.72 (dd, J = 5.5, 3.1 Hz, 2H), 7.46 (d, J = 8.1 
Hz, 1H), 7.31 (ddd, J = 8.1, 8.1, 1.0 Hz, 1H), 7.13 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.07 (ddd, J = 
10.5, 5.8, 2.2 Hz, 1H), 6.13 (br d, J = 8.1 Hz, 1H), 4.92 (dt, J = 8.2, 6.0 Hz, 1H), 4.05 – 3.89 (m, 
2H), 3.66 (s, 3H), 3.33 – 2.98 (m, 4H), 1.93 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 172.7, 
169.8, 168.3, 135.6, 134.2, 132.5, 131.9, 128.6, 123.5, 121.8, 119.7, 118.2, 110.8, 107.4, 52.9, 
52.4, 37.0, 27.0, 25.3, 23.1; IR (NaCl/thin film): 3369, 3280, 3052, 2948, 1770, 1738, 1711, 
1659, 1530, 1438, 1397, 1371; [α]D25 = +14.8 (c = 0.96, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 355.1452, found 355.1455. 
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(S)-Nα-Acetyltryptophan methyl ester and indole dimer 
Prepared from indole (23.4 mg, 0.20 mmol) following General Procedure 2.  The crude residue 
was purified by silica gel chromatography (0:100 to 100:0 EtOAc:hexanes) to yield 17.9 mg 
(contains 9 wt % EtOAc, 31% corrected yield) of (S)-Nα-acetyltryptophan 
methyl ester as a light pink oil and 7.0 mg (30% yield) of an indole dimer 
as a  light yellow oil.  The enantiomeric excess of (S)-Nα-
acetyltryptophan methyl ester was determined to be 67% by chiral SFC 
analysis (OD-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR(major) = 
11.4 min, tR(minor) = 10.6 min. [α]D25 = +39.3 (c = 0.83, CHCl3).  
Spectral data for both (S)-Nα-acetyltryptophan methyl ester20 and the indole dimer21 are in 
agreement with the literature. 
 
 
 
 
 
 
                                                        20 Ruis-Rodríguez, J.; Albericio, F.; Lavilla, R. Chem. Eur. J. 2010, 16, 1124. 21 Xu, X.-H.; Liu, G.-K.; Azuma, A.; Tokunaga, E.; Shibata, N. Org. Lett. 2011, 13, 4854. 
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5. SFC traces for racemic and enantioenriched tryptophan derivatives. 
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7a (Table 2, entry 1): enantioenriched, 35% ee 
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7b (Table 2, entry 2): racemic 
 
 
 
 
 
7b (Table 2, entry 2): enantioenriched, 42% ee 
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7c: racemic 
 
 
 
 
 
7c (Table 2, entry 3, no additive, DCM as solvent): enantioenriched, 78% ee 
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7c (Table 2, entry 6, with K2CO3, DCM as solvent): enantioenriched, 78% ee 
 
 
 
 
 
7c (Table 2, entry 8, with 4Å MS, DCM as solvent): enantioenriched, 81% ee 
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7c (Table 2, entry 9, with 4Å MS, DCE as solvent): enantioenriched, 79% ee 
 
 
 
 
 
7c (Table 2, entry 10, with 4Å MS, CHCl3 as solvent): enantioenriched, 72% ee 
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7c (Table 3, entry 2, (R)-3,3’-diphenyl-BINOL (9b)): enantioenriched, 37% ee 
 
 
 
 
 
7c (Table 3, entry 3, (R)-3,3’-dimethyl-BINOL (9c)): enantioenriched, 87% ee 
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7c (Table 3, entry 4, (R)-3-chloro-BINOL (9d)): enantioenriched, 84% ee 
 
 
 
 
 
7c (Table 3, entry 5, (R)-3,3’-dichloro-BINOL (9e)): enantioenriched, 90% ee 
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7c (Table 3, entry 6, (R)-3,3’-dibromo-BINOL (9f)): enantioenriched, 93% ee 
 
 
 
 
 
 
7c (Table 3, entry 7, (R)-3,3’-dimethoxy-BINOL (9g)): enantioenriched, 1% ee 
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7c (Table 3, entry 8, (R)-6,6’-dimethoxy-BINOL (9h)): enantioenriched, 54% ee 
 
 
 
 
 
 
7c (Table 3, entry 9, (R)-6,6’-dimethyl-BINOL (9i)): enantioenriched, 78% ee 
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78% ee
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7c (Table 3, entry 10, (R)-6,6’-dibromo-BINOL (9j)): enantioenriched, 78% ee 
 
 
 
 
 
 
7c (Table 3, entry 12, 15 mol % 9f): enantioenriched, 93% ee 
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78% ee
N
H
Ph
CO2Me
NHAc
7c
93% ee
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7c (Table 3, entry 13, 10 mol % 9f): enantioenriched, 92% ee 
 
 
 
 
 
 
 
7c (Table 3, entry 14, 5 mol % 9f): enantioenriched, 88% ee 
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Substrate scope of the conjugate addition/asymmetric protonation  
 
7d (Table 4, entry 2): racemic 
 
 
 
 
 
7d (Table 4, entry 2): enantioenriched, 85% ee 
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85% ee
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7e (Table 4, entry 3): racemic 
 
 
 
 
 
 
 
7e (Table 4, entry 3): enantioenriched, 85% ee 
 
7e
racemic
N
Ph
CO2Me
NHAc
7e
85% ee
N
Ph
CO2Me
NHAc
  S39 
 
7f (Table 4, entry 4): racemic 
 
 
 
 
 
 
3e (Table 2, entry 3): enantioenriched, 96% ee 
 
 
 
 
 
7f
racemic
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H
Ph
CO2Me
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Me
7f
96% ee
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Ph
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Me
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7g (Table 4, entry 5): racemic 
 
 
 
 
 
 
7g (Table 4, entry 5): enantioenriched, 95% ee 
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racemic
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H
Ph
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Me
7g
95% ee
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Ph
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Me
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7h (Table 4, entry 6): racemic 
 
  
 
 
 
7h (Table 4, entry 6): enantioenriched, 89% ee 
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7i (Table 4, entry 7): racemic 
 
 
 
 
 
7i (Table 4, entry 7): enantioenriched, 94% ee 
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racemic
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Ph
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Me
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94% ee
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Me
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7j (Table 4, entry 8): racemic 
 
 
 
 
 
7j (Table 4, entry 8): enantioenriched, 91% ee 
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7k (Table 4, entry 9): racemic 
 
 
 
 
 
7k (Table 4, entry 9): enantioenriched, 93% ee 
 
 
 
7k
racemic
N
H
Ph
CO2Me
NHAc
Br
7k
93% ee
N
H
Ph
CO2Me
NHAc
Br
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7l (Table 4, entry 10): racemic 
 
 
 
 
 
7l (Table 4, entry 10): enantioenriched, 92% ee 
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92% ee
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7m (Table 4, entry 11): racemic 
 
 
 
 
 
7m (Table 4, entry 11): enantioenriched, 94% ee 
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H
CO2Me
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94% ee
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7n (Table 4, entry 12): racemic 
 
 
 
 
 
7n (Table 4, entry 12): enantioenriched, 87% ee 
 
 
N
H
CO2Me
NHAc
Me
7n
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N
H
CO2Me
NHAc
Me
7n
87% ee
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7o (Table 4, entry 13): racemic 
 
  
 
 
 
7o (Table 4, entry 13): enantioenriched, 93% ee 
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H
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93% ee
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H
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Cl
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7p (Table 4, entry 14): racemic 
 
 
 
 
 
7p (Table 4, entry 14): enantioenriched, 93% ee 
 
 
 
 
 
 
N
H
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7p
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CO2Me
NHAc
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H
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93% ee
CO2Me
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7q (Table 4, entry 15): racemic 
 
 
 
 
 
7q (Table 4, entry 15): enantioenriched, 92% ee 
 
 
N
H
NHAc
CO2Me
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racemic
N
H
NHAc
CO2Me
F
7q
92% ee
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7r (Table 4, entry 16): racemic 
 
 
 
 
 
7r (Table 4, entry 16): enantioenriched, 92% ee 
 
 
 
 
 
N
H
CO2Me
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92% ee
N
H
CO2Me
NHAc
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7r
racemic
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7s (Table 4, entry 17): racemic 
 
 
 
 
 
7s (Table 4, entry 17): enantioenriched, 92% ee 
 
 
 
 
 
 
N
H
NHAc
CO2Me
OMe
7s
racemic
N
H
NHAc
CO2Me
OMe
7s
92% ee
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7t (Table 4, entry 18): racemic 
 
 
 
 
 
7t (Table 4, entry 18): enantioenriched, 85% ee 
 
  
N
H
CO2Me
NHAc
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racemic
Me
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NHAc
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85% ee
Me
  S54 
7u (Table 4, entry 19): racemic 
 
 
 
 
 
7u (Table  4, entry 19): enantioenriched, 91% ee 
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91% ee
Me
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7v (Table 4, entry 20): racemic 
 
 
 
 
 
7v (Table 4, entry 20): enantioenriched, 92% ee 
 
 
 
 
 
 
N
H
NHAc
CO2Me
7v
racemic
N
H
NHAc
CO2Me
7v
92% ee
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7w (Table 4, entry 21): racemic 
 
 
 
 
 
7w (Table 4, entry 21): enantioenriched, 84% ee 
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H
NHAc
CO2Me
7w
racemic
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H
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84% ee
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3x (Table 4, entry 22): racemic 
 
 
 
 
 
 
3x (Table 4, entry 22): enantioenriched, 90% ee 
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90% ee
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(S)-Nα-Acetyltryptophan methyl ester: racemic 
 
 
 
 
 
 
(S)-Nα-Acetyltryptophan methyl ester: enantioenriched, 67% ee 
 
 
 
 
 
 
racemic
N
H
CO2Me
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67% ee
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H
CO2Me
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6. Scale-up Procedure. 
N
H
Ph
NHAc
(1.2 equiv)
SnCl4 (1.0 equiv)
9f (20 mol %)
4Å MS (200 wt %)
DCM, 23 ºC, 2 h
N
H
Ph
CO2Me
O
MeO
NHAc2c
6a 7c
93% ee
(78% yield)  
To a flame-dried flask under nitrogen containing freshly activated powdered 4Å molecular sieves 
(200 wt %) was added 2-phenylindole (1a, 1.00 g, 5.20 mmol, 1.00 equiv), methyl 2-
acetamidoacrylate (2c, 890 mg, 6.20 mmol, 1.20 equiv), and (R)-3,3’-dibromo-BINOL (9f, 457 
mg, 1.00 mmol, 0.20 equiv).  The flask was charged with DCM (40 mL) and SnCl4 (1 M in 
DCM, 5.20 mL, 5.20 mmol, 1.00 equiv) was added. The reaction was stirred at room temperature 
for 2 hours, then quenched by addition of 1 M HCl (50 mL).  The aqueous layer was extracted 
with EtOAc (2 x 50 mL) and the combined organic layers were washed with saturated  aqueous 
NaHCO3 (50 mL), dried (Na2SO4), filtered and concentrated.  The crude residue was purified by 
silica gel chromatography (40:60 to 100:0 EtOAc:hexanes) to yield 1.33 g (77% yield) of 7c  as a 
pale yellow foam. The enantiomeric excess was determined to be 93% by chiral SFC analysis 
(AD-H, 2.5 mL/min, 30% IPA in CO2, λ = 254 nm):  tR(major) = 5.7 min, tR(minor) = 6.9 min. 
 
 
 
 
 
7c
93% ee
N
H
Ph
CO2Me
NHAc
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7. Functionalization of tryptophans 7c and 7d. 
 
Acetamide hydrolysis of 7c22 
 
N
H
Ph
CO2Me
NHAc
N
H
Ph
CO2Me
NH2
1:1:1 
MeOH:H2O:
conc. HCl
(76% yield)
75 °C, 12 h
10
93% ee
7c
93% ee  
 
A vial was charged with (S)-Nα-acetyl-2-phenyltryptophan methyl ester (7c, 30.0 mg, 0.09 
mmol), MeOH (1 mL), H2O (1 mL) and aqueous HCl (12 M, 1 mL).  The reaction was heated to 
75 °C for 12 hours, then concentrated, redissolved in DCM (10 mL) and washed with saturated 
aqueous NaHCO3 (3 X 5 mL).  The aqueous layers were combined and extracted with DCM (4 X 
5 mL).  The combined organic layers were washed with brine, dried (Na2SO4), filtered and 
concentrated.  The crude residue was purified by silica gel chromatography (99:1 
CH2Cl2:MeOH) to yield 20.0 mg (76% yield) of 10 as a light yellow oil. The enantiomeric 
excess was determined by chiral SFC analysis of the corresponding methylcarbamate S9 (see 
below). 1H NMR (500 MHz, CDCl3) δ 8.18 (br s, 1H), 7.67 (dd, J = 7.6, 0.7 Hz, 1H), 7.62 – 7.60 
(m, 2H), 7.50 – 7.43 (m, 2H), 7.41 – 7.34 (m, 2H), 7.22 (ddd, J = 8.1, 7.1, 1.2 Hz, 1H), 7.15 
(ddd, J = 7.9, 7.0, 1.0 Hz, 1H), 3.89 (dd, J = 8.4, 5.0 Hz, 1H), 3.56 (s, 3H), 3.47 – 3.38 (m, 1H), 
3.27 – 3.14 (m, 1H), 1.69 (br s, 2H); 13C NMR (125 MHz, CDCl3) δ 175.5, 136.1, 135.8, 132.9, 
129.1, 129.0, 128.3, 128.0, 122.5, 119.9, 119.2, 110.9, 108.2, 55.2, 51.9, 30.2; IR (NaCl/thin 
film): 3367, 3062, 2948, 1732, 1603, 1489, 1457, 1207; [α]D25 = -12.4 (c = 0.85, CHCl3). HRMS 
(MM) calc’d for [M+H]+ 295.1441, found 295.1446. 
 
 
 
 
 
 
 
                                                         22 For an analogous hydrolysis procedure, see: Messina, F.; Botta, M.; Corelli, F.; Schneider, M.; Fazio, 
F. J. Org. Chem. 1999, 64, 3767. 
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Methylcarbamate Protection 
 
N
H
Ph
CO2Me
NH2
10
93% ee
MeO Cl
O
N
H
HN
Ph
S9
93% ee
(80% yield)
Et3N, CH2Cl2
CO2Me
O
OMe
 
 
A flame-dried flask was charged with free amine 10 (19.5 mg, 0.70 mmol, 1.00 equiv), Et3N (19 
µL, 0.13 mmol, 2.0 equiv) and DCM (5 mL). Methylchloroformate (6.0 µL, 0.73 mmol, 1.10 
equiv) was added and the solution was stirred at room temperature for 3 hours, then quenched 
with saturated aqueous NH4Cl (5 mL) and extracted with EtOAc (2 X 5 mL).  The combined 
organic layers were dried (Na2SO4), filtered and concentrated.  The crude residue was purified by 
silica gel chromatography (25:75 EtOAc:hexanes) to yield 18.5 mg (80% yield) of 
methylcarbamate S9 as a colorless oil.  The enantiomeric excess was determined to be 93% by 
chiral SFC analysis (OD-H, 2.5 mL/min, 15% IPA in CO2, λ = 254 nm): tR(major) = 16.7 min, 
tR(minor) = 15.6 min.  1H NMR (500 MHz, CDCl3) δ 8.11 (br s, 1H), 7.61 (d, J = 7.9 Hz, 1H), 
7.57 – 7.52 (m, 1H), 7.48 – 7.45 (m, 2H), 7.40 – 7.35 (m, 2H), 7.25 – 7.19 (m, 1H), 7.16 (m, 
1H), 5.06 (br d, J = 7.7 Hz, 1H), 4.63 – 4.59 (m, 1H), 3.54 (s, 3H), 3.50 (m, 2H), 3.38 (s, 3H); 
13C NMR (125 MHz, CDCl3) δ 172.3, 156.1, 136.2, 135.7, 132.9, 129.2, 129.0, 128.3, 128.0, 
122.5, 120.0, 118.9, 110.9, 106.7, 54.5, 52.12, 52.07, 27.1; IR (NaCl/thin film) 3338, 2953, 
2923, 2852, 1718, 1701, 1507, 1457, 1363, 1213, 1072 cm-1; [α]D25 = +22.6 (c = 0.10, CHCl3). 
HRMS (MM) calc’d for [M+H]+ 353.1496, found 353.1497. 
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Methylcarbamate (S9): racemic 
 
        
Methylcarbamate (S9): enantioenriched, 93% ee 
 
 
 
 
 
 
 
 
N
H
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Ph
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racemic
CO2Me
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93% ee
CO2Me
O
OMe
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Methyl ester hydrolysis23 
N
H
Ph
CO2Me
NHAc
N
H
Ph
CO2H
NHAc
LiOH, 
4:1 THF:H2O
(92% yield)
11
92% ee
0 °C, 2.5 h
7c
93% ee  
A 10 mL flask was charged with (S)-Nα-acetyl-2-phenyltryptophan methyl ester 7c (67.2 mg, 
0.20 mmol, 1.00 equiv) and THF (0.9 mL) then cooled to 0 ºC, followed by dropwise addition of 
aqueous LiOH (1.75 M, 230 µL, 0.40 mmol, 2.00 equiv).  The reaction was vigorously stirred at 
0 ºC for 2 hours, then diluted with H2O (15 mL) and extracted with EtOAc (2 x 10 mL).  The 
aqueous layer was acidified to pH = 1.5 and extracted with EtOAc (5 x 15 mL).  The combined 
organic layers from the acidic aqueous extraction were dried (Na2SO4), filtered, and 
concentrated.  The crude residue was purified by silica gel chromatography (0:99:1 to 15:84:1 
MeOH:DCM:AcOH) to yield 59.2 mg (92% yield) of carboxylic acid 11 as a pale yellow foam. 
The enantiomeric excess was determined to be 92% by chiral SFC analysis (AS-H, 2.5 mL/min, 
28% IPA in CO2, λ = 254 nm): tR(major) = 4.5 min, tR(minor) = 8.0 min.  1H NMR (500 MHz, 
CDCl3) δ 8.21 (br s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.56 – 7.51 (m, 2H), 7.47 (dd, J = 7.6, 7.6 Hz, 
2H), 7.40 (m, 1H), 7.37 (ddd, J = 8.0, 0.8, 0.8 Hz, 1H), 7.21 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.14 
(ddd, J = 8.0, 7.1, 1.0 Hz, 1H), 5.72 (br d, J = 7.4 Hz, 1H), 4.73 (td, J = 7.1, 5.4 Hz, 1H), 3.56 
(dd, J = 14.9, 5.2 Hz, 1H), 3.49 (dd, J=15.0, 6.9 Hz, 1H), 1.62 (s, 3H); 13C NMR (125 MHz, 
CDCl3) δ 174.7, 170.9, 136.2, 135.7, 132.9, 129.13, 129.05, 128.3, 128.2, 122.6, 120.1, 118.8, 
111.0, 106.8, 53.1, 26.2, 22.6; IR (NaCl/thin film): 3391, 3306, 3055, 3011, 2921, 2850, 1717, 
1615, 1527, 1457, 1448, 1215 cm-1; [α]D25 = +9.2 (c = 1.05, MeCN). HRMS (MM) calc’d for 
[M+H]+ 323.1390, found 323.1390. 
 
 
 
                                                         23 For an analogous hydrolysis procedure, see: Morieux, P.; Stables, J.P.; Kohn, H. Bioorg. Med. Chem. 
2008, 16, 8968. 
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11: racemic 
 
 
 
 
 
11: enantioenriched, 92% ee 
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NHAc
11
racemic
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Preparation of bromo-dehydroindoline 12. 
 
NBS, TFA, DCM, –50 ºC
N
H
Ph
CO2Me
NHAc
N Ph
Br
12
1:1 dr
92:90% ee
7c
93% ee
(79% yield)
CO2Me
NHAc
 
 
A solution of (S)-Nα-acetyl-2-phenyltryptophan methyl ester 7c (101 mg, 0.30 mmol, 1.00 equiv) 
in DCM (8.4 mL) was cooled to –50 ºC in an acetonitrile/dry ice bath.  NBS (53.4 mg, 0.30 
mmol, 1.00 equiv) was then added, followed by TFA (900 µL).  The reaction was stirred in the 
dark at –50 ºC for 3 hours, then poured onto ice, quenched with aqueous ammonia (1.5 mL) and 
extracted with DCM (3 x 25 mL).  The combined organics were washed (40 mL H2O, then 40 
mL brine), dried (Na2SO4), filtered, and concentrated.  The product 12 was formed in a 1:1 ratio 
of diastereomers (determined by 1H NMR analysis of the crude reaction mixture) and was 
purified by silica gel chromatography (30:70 to 70:30 EtOAc:hexanes) to yield 98 mg (79% 
yield) of the combined diastereomers as a bright yellow foam.  The enantiomeric excesses of the 
two diastereomers were determined to be 92% and 90% by chiral SFC analysis (AS-H, 2.5 
mL/min, 20% IPA in CO2, λ = 254 nm): tR(major) = 3.8 min, tR(minor) = 4.1 min; tR(major) = 
4.6 min, tR(minor) = 6.0 min. Spectral data and optical rotation are reported for the mixture of 
diastereomers.  1H NMR (500 MHz, CDCl3) δ 8.42 – 8.32 (m, 4H), 7.70 – 7.64 (m, 2H), 7.57 – 
7.49 (m, 8H), 7.47 – 7.40 (m, 2H), 7.39 – 7.30 (m, 2H), 5.37 (br d, J = 7.4 Hz, 1H), 5.05 (br d, J 
= 8.5 Hz, 1H), 4.33 (dt, J = 7.5, 5.5 Hz, 1H), 3.95 (td, J = 8.9, 4.0 Hz, 1H), 3.56 (dd, J = 14.8, 
5.2 Hz, 1H), 3.47 – 3.41 (m, 4H), 3.38 – 3.32 (m, 4H), 3.23 (dd, J = 14.6, 9.3 Hz, 1H), 1.45 (s, 
3H), 1.27 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 175.6, 174.8, 170.7, 170.0, 169.4, 169.2, 
151.82, 151.76, 139.8, 139.6, 131.6, 131.4, 131.3, 130.5, 130.4, 128.81, 128.80, 128.71, 128.70, 
127.2, 126.6, 123.2, 122.5, 121.9, 121.7, 59.16, 59.14, 52.5, 52.3, 50.3, 49.8, 41.6, 41.4, 22.3, 
22.0; IR (NaCl/thin film): 3271, 3062, 2952, 2924, 2853, 1747, 1661, 1525, 1444, 1372, 1264, 
1216 cm-1; [α]D25 = +17.1 (c = 0.50, CHCl3). HRMS (MM) calc’d for M+ 415.0652, found 
415.0652. 
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Bromo-dehydroindoline 12: 1:1 mixture of diastereomers, racemic 
 
 
 
 
 
 
Bromo-dehydroindoline 12: 1:1 mixture of diastereomers, enantioenriched, 92:90% ee 
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Preparation of 3-hydroxypyrroloindoline 13 
(i)  NCS, TFA, MeCN, 23 ºC
N
Me
Ph
7d
CO2Me
NHAc
endo-13
(ii) SiO2, 1.7:1 MeCN:H2O N
Ac
N
Me
O
CO2Me
H
H
H
HH
H
nOe
nOe
nOe
   6                         :                       1
+
N
Ac
N
Me
O
CO2Me
H
H
H
HH
H
nOe
nOe
exo-13
(52% yield)
(84% ee) (85% ee)
(85% ee)
 
 
A 15 mL flask containing (S)-Nα-acetyl-1-methyl-2-phenyltryptophan methyl ester 7d (52.5 mg, 
0.150 mmol, 1.00 equiv) was flushed with argon and then charged with MeCN (3.3 mL). TFA 
was added as a solution in MeCN (1.3 M, 125 µL, 0.150 mmol, 1.00 equiv), followed by NCS as 
a solution in MeCN (0.2 M, 0.75 mL, 0.150 mmol, 1.00 equiv).  The flask was then sealed under 
argon and the solution was stirred in the dark at room temperature.  After 3 hours, the reaction 
was quenched with aqueous ammonia (1.5 mL), poured onto ice, and extracted with DCM (3 x 
15 mL).   The combined organics were washed (20 mL H2O, then 20 mL brine), dried (Na2SO4), 
filtered, and concentrated to give the crude mixture of 3-chloropyrroloindoline diastereomers 
(detected by HRMS direct injection (MM) calc’d for [M+H]+ 385.1313, found 385.1320).  The 
crude residue was redissolved in MeCN (2 mL), then H2O (1.2 mL) and SiO2 (2.5 mL) were 
added.  The mixture was vigorously stirred open to air at room temperature for 30 minutes, then 
filtered through a 1.5 mL silica plug with EtOAc (50 mL), dried (Na2SO4), filtered and 
concentrated.  The 3-hydroxypyrroloindoline 13 existed in a 6:1 ratio of diastereomers, favoring 
the endo diastereomer (determined by 1H NMR analysis of the crude reaction mixture) and was 
purified by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to yield 30.8 mg 
(contains 18 wt % CHCl3, 46% corrected yield) of the endo diastereomer as a yellow oil.  The 
exo diastereomer, obtained post chromatography in a mixture with (S)-Nα-acetyl-1-methyl-2-
phenyltryptophan methyl ester 7d, was subjected to reverse phase preparatory HPLC (30:70 to 
90:10 MeCN:H2O) using an Agilent 1200 Series HPLC with an Agilent XDB-C18 5 µM column 
(9.4 x 250 mm) to yield 3.5 mg (6% yield) of the exo diastereomer as a yellow oil. 
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Endo diastereomer: 
The enantiomeric excess was determined to be 84% by chiral SFC analysis (AD-H, 2.5 mL/min, 
25% IPA in CO2, λ = 254 nm): tR(major) = 7.4 min, tR(minor) = 4.7 min.  The relative 
stereochemistry was assigned by 2D NMR analysis. 1H NMR (500 
MHz, CD3CN; compound exists as a 15:1 mixture of rotamers, the 
major rotamer is reported) δ 7.40 – 7.35 (m, 2H), 7.34 – 7.26 (m, 3H), 
7.20 (ddd, J = 7.9, 7.5, 1.3 Hz, 1H), 7.12 (ddd, J = 7.2, 1.3, 0.5 Hz, 
1H), 6.66 (ddd, J = 7.3, 7.3, 1.0 Hz, 1H), 6.51 (d, J = 7.9 Hz, 1H), 
4.79 (d, J = 8.8 Hz, 1H), 3.19 (s, 3H), 2.97 (s, 3H), 2.90 (br s, 1H), 2.82 (d, J = 12.7 Hz, 1H), 
2.59 (ddd, J = 12.7, 8.8, 1.1 Hz, 1H), 1.95 (s, 3H); 13C NMR (125 MHz, CD3CN; compound 
exists as a 15:1 mixture of rotamers, the major rotamer is reported) δ 172.0, 171.3, 153.1, 138.0, 
131.6, 128.9, 128.6, 128.3, 125.2, 118.0, 107.1, 95.3, 88.3, 61.3, 52.7, 39.0, 32.7, 23.6; IR 
(NaCl/thin film): 3292, 3010, 2948, 1735, 1653, 1648, 1610, 1491, 1448, 1388, 1313, 1220 cm-1; 
[α]D25 = +264.0 (c = 1.35, CHCl3). HRMS (MM) calc’d for [M+H]+ 367.1652, found 367.1650. 
Exo diastereomer: 
The enantiomeric excess was determined to be 85% by chiral SFC 
analysis (OD-H, 2.5 mL/min, 20% IPA in CO2, λ = 254 nm): 
tR(major) = 6.2 min, tR(minor) = 4.0 min. The relative stereochemistry 
was assigned by 2D NMR analysis. 1H NMR (500 MHz, CD3CN; 
compound exists as a 1.5:1 mixture of rotamers, the major rotamer is 
denoted by *, the minor rotamer by §) δ 7.60 – 7.22 (m, 6H*, 7H§), 7.17 (ddd, J = 7.3, 0.6, 0.6 
Hz, 1H*), 6.79 (dd, J = 7.5, 7.5 Hz, 1H§), 6.70 (dd, J = 7.5, 7.5 Hz, 1H*), 6.65 (d, J = 7.9 Hz, 
1H§), 6.54 (d, J = 7.9 Hz, 1H*), 4.49 (dd, J = 8.0, 6.7 Hz, 1H*), 4.07 (dd, J = 10.0, 6.9 Hz, 1H§), 
3.81 (s, 3H*), 3.71 (s, 3H§), 3.34 (s, 1H§), 3.01 (s, 1H*), 2.963 (s, 3H*), 2.958 (s, 3H§), 2.71 (dd, 
J = 13.0, 8.1 Hz, 1H*), 2.68 (dd, J = 12.6, 7.0 Hz, 1H§), 2.34 (dd, J = 12.9, 6.7 Hz, 1H*), 2.07 
(dd, J = 12.7, 10.0 Hz, 1H§), 1.89 (s, 3H*), 1.80 (s, 3H§); 13C NMR (125 MHz, CD3CN) δ 174.1, 
173.6, 172.3, 171.8, 151.2, 151.1, 136.3, 136.2, 131.6, 131.3, 130.3, 129.60, 129.57, 129.4, 
128.7, 128.6, 124.4, 123.9, 119.3, 118.2, 108.0, 106.4, 98.8, 96.1, 90.1, 88.5, 61.2, 60.3, 53.3, 
52.6, 40.9, 37.2, 33.4, 32.4, 24.6, 23.8; IR (NaCl/thin film): 3305, 2924, 1747, 1646, 1610, 1491, 
1448, 1381, 1311, 1207 cm-1; [α]D25 = -138.2 (c = 0.33, CHCl3). HRMS (MM) calc’d for 
[M+H]+ 367.1652, found 367.1655. 
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Endo-13: racemic 
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Exo-13: racemic 
 
 
 
 
 
 
 
Exo-13: enantioenriched, 85% ee 
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8. Scalemic (R)-BINOL Experiment. 
N
H
Ph
NHAc
(1.0 equiv)
SnCl4 (1.2 equiv)
(R)-BINOL 9a (20 mol %)
DCM, 23 ºC
N
H
Ph
CO2Me
O
MeO
NHAc2c
6a 7c  
A flame-dried flask was charged with 2-phenylindole (6a, 19.0 mg, 0.10 mmol, 1.00 equiv) and 
methyl 2-acetamidoacrylate (2c, 14.0 mg, 0.10 mmol, 1.00 equiv). Stock solutions of (R)- 
BINOL (9a) and racemic BINOL were prepared (0.0134 M in DCM) and the appropriate volume 
of each solution was added to the flask (0.02 mmol, 0.20 equiv).  The reaction was charged with 
SnCl4 as a solution in DCM (1 M, 120 µL, 0.12 mmol, 1.20 equiv) and stirred at room 
temperature for 2 hours, then quenched by dilution with 1 M HCl (5 mL) and MeCN (1 mL).  
The aqueous layer was extracted with EtOAc (2 x 5 mL) and the combined organic layers were 
washed with saturated aqueous NaHCO3 (5 mL), dried (Na2SO4), filtered, and concentrated. The 
crude residue was purified by silica gel chromatography (40:60 to 100:0 EtOAc:hexanes).  The 
enantiomeric excess of each experiment was determined by chiral SFC analysis (AD-H, 2.5 
mL/min, 30% IPA in CO2, λ = 254 nm). 
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9. Deuterium labeling studies. 
 
Preparation of N-deuteroacrylate (S10). 
 
O
OMe
N
O
H
MeOD
O
OMe
N
O
D
>99% D
2c S10
 
 
Acrylate 2c was dissolved in MeOD (1 mL) under nitrogen.  After stirring for 1 minute, the 
solution was concentrated under high vacuum.  This procedure was repeated three times to give 
>99% deuterium incorporation. 
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Preparation of per-deutero-2-phenylindole (S11). 
 
N
H
Ph
1:1 MeOD:D2O
Me Cl
O
microwave
140 ºC N
Ph
D
D
D
D
D
D
6a S11
90% D  
 
To MeOD (1 mL) in a microwave vial was added acetyl chloride (100 µL), followed by 2-
phenylindole (6a, 50 mg) and D2O (1 mL).  The vial was sealed and heated in a microwave to 
140 °C for 1 hour.  Upon cooling, the heterogenous solution was diluted with DCM.  The phases 
were separated and the aqueous was extracted with DCM (2 x 5 mL).  The combined organic 
layers were dried (Na2SO4), filtered and concentrated to give per-deutero-2-phenylindole (S11) 
with 90% deuterium incorporation. 
N
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D
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D
D
D
90% D
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10. 1H NMR Kinetics Experiment for SnCl4 and (R)-BINOL (9a)•SnCl4 promoted reaction 
of 6a and 2c. 
N
H
Ph
NHAc
(1.0 equiv)
SnCl4 (1.2 equiv)
(R)-BINOL 9a (0 or 20 mol %)
CD2Cl2, 23 ºC
N
H
Ph
CO2Me
O
MeO
NHAc2c
6a 7c  
 
An oven-dried vial was charged with 2-phenylindole (6a, 19.0 mg, 0.10 mmol, 1.00 equiv), 
methyl 2-acetamidoacrylate (2c, 14.0 mg, 0.10 mmol, 1.00 equiv), (R)-BINOL if necessary (9a, 
6.0 mg, 0.02 mmol, 0.20 equiv) and 1,4-diethylbenzene (4.7 µL, 0.03 mmol, 0.30 equiv) as the 
internal standard.  The vial was pumped into a glove box and charged with CD2Cl2 (0.75 mL, to 
an indole concentration of 0.12 M), then transferred to a screw-cap NMR tube. A 1H NMR 
spectrum (1 scan) was taken to determine the inital ratio of acrylate and 1,4-diethylbenzene. 
SnCl4 (1 M in CD2Cl2, 120 µL, 0.12 mmol, 1.20 equiv) was then added through the septum of the 
screw-cap and the NMR tube was inverted once and quickly inserted into the spectrometer.  The 
concentration of acrylate was monitored by 1H NMR over 9 hours and was determined by 
integration of its resonance at 3.83 ppm relative to 1,4-diethylbenzene’s resonance at 2.74 ppm. 
 
Kinetics Plot 
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11. Comparison of conditions for pyrroloindoline formation.  
 
Table 5, entry 1: 
N
Me
Me
CO2MeAcHN
SnCl4
(R)-BINOL 9a
DCM, 23 ºC
N
Ac
N
Me
Me
CO2Me
H
1a 2c 3k
(70% yield)
(5:1 dr, 66:80% ee)  
To a flame-dried 10 mL flask was added 1,3-dimethylindole (1a, 29.0 mg, 0.20 mmol, 1.00 
equiv), acrylate 2c (28.6 mg, 0.20 mmol, 1.00 equiv), and (R)-BINOL (9a, 11.4 mg, 0.04 mmol, 
0.20 equiv).  The flask was charged with DCM (1.5 mL), followed by addition of SnCl4 (1 M in 
DCM, 240 µL, 0.24 mmol, 1.20 equiv) and the reaction mixture was stirred at room temperature 
for 4 hours, then quenched by diluting with MeCN (1 mL) and 1 M HCl (5 mL).  The aqueous 
layer was extracted with EtOAc (3 x 5 mL) and the combined organic layers were washed with 
saturated aqueous NaHCO3 (15 mL).  The aqueous layer was back extracted with EtOAc (10 mL) 
and the combined organic layers were dried (Na2SO4), filtered, and concentrated.  The product 
3k was formed in a 5:1 ratio of diastereomers favoring the exo diastereomer (determined by 1H 
NMR analysis of the crude reaction mixture) and purified by silica gel chromatography (0:100 to 
100:0 EtOAc:hexanes) to yield 40.1 mg (70% yield) of the combined diastereomers as a yellow 
oil.  The enantiomeric excess of the exo diastereomer was determined to be 66% by chiral SFC 
analysis (AD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 9.0 min, tR(minor) = 
5.8 min.  The enantiomeric excess of the endo diastereomer was determined to be 80% by chiral 
SFC analysis (AD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 3.8 min, tR(minor) 
= 4.5 min.  Spectral data are in agreement with the literature.24 
 
 
 
 
 
                                                        24 Repka, L. M.; Ni, J.; J. Reisman. S. E. J. Am. Chem. Soc. 2010, 132, 14418. 
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3k (Table 5, entries 1-2): racemic 
 
 
 
 
 
 
3k (Table 5, entry 1): enantioenriched, exo: 66% ee, endo: 80% ee 
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Table 5, entry 2: 
 
N
Me
Me
CO2MeAcHN
SnCl4
(R)-3,3'-dibromo-BINOL 9f
DCM, 4Å MS, 20 ºC N
Ac
N
Me
Me
CO2Me
H
1a 2c 3k
(58% yield)
(8:1 dr, 87:85% ee)  
An oven-dried vial was charged with 1,3-dimethylindole (1a, 29.0 mg, 0.20 mmol, 1.00 equiv), 
acrylate 2c (34.3 mg, 0.24 mmol, 1.20 equiv), and (R)-3,3’-dibromo-BINOL (9f, 17.8 mg, 0.04 
mmol, 0.20 equiv) and pumped into a glove box. To the vial was added flame-dried powdered 
4Å molecular sieves (200 wt % relative to 1a). The vial was charged with DCM (1.5 mL) and 
SnCl4 (1 M in DCM, 200 µL, 0.20 mmol, 1.00 equiv) was added. The reaction was stirred at 20 
°C for 4 hours, after which time it was removed from the glove box and quenched by dilution 
with 1 M HCl (5 mL) and MeCN (1 mL). The aqueous layer was extracted with EtOAc (3 x 5 
mL) and the combined organic layers were washed with saturated aqueous NaHCO3 (15 mL).  
The aqueous was back extracted with EtOAc (10 mL) and the combined organic layers were 
dried (Na2SO4), filtered, and concentrated. The product 3k was formed in a 8:1 ratio of 
diastereomers favoring the exo diastereomer (determined by 1H NMR analysis of the crude 
reaction mixture) and purified by silica gel chromatography (0:100 to 100:0 EtOAc:hexanes) to 
yield 33.5 mg (58% yield) of the combined diastereomers as a yellow oil.  The enantiomeric 
excess of the exo diastereomer was determined to be 87% by chiral SFC analysis (AD-H, 2.5 
mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 8.9 min, tR(minor) = 5.7 min.  The 
enantiomeric excess of the endo diastereomer was determined to be 85% by chiral SFC analysis 
(AD-H, 2.5 mL/min, 10% IPA in CO2, λ = 254 nm): tR(major) = 3.7 min, tR(minor) = 4.4 min.  
Spectral data are in agreement with the literature.24     
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3k (Table 5, entry 2): enantioenriched, exo: 87% ee, endo: 85% ee 
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Table 5, entry 4:25  
N
Me
Me
CO2BnTFAHN DCM, 4Å MS, 20 ºC N
TFA
N
Me
Me
CO2Bn
H
1a 2a 3a
(39% yield)
(7:1 dr, 98:92% ee)
SnCl4
(R)-3,3'-dibromo-BINOL 9f
 
An oven-dried vial was charged with 1,3-dimethylindole (1a, 29.0 mg, 0.20 mmol, 1.00 equiv), 
acrylate 2a (65.5 mg, 0.24 mmol, 1.20 equiv), and (R)-3,3’-dibromo-BINOL (9f, 17.8 mg, 0.04 
mmol, 0.20 equiv) and pumped into a glove box. To the vial was added flame-dried powdered 
4Å molecular sieves (200 wt % relative to 1a). The vial was charged with DCM (1.5 mL) and 
SnCl4 (1 M in DCM, 200 µL, 0.20 mmol, 1.00 equiv) was added. The reaction was stirred at 20 
°C for 4 hours, after which time it was removed from the glove box and quenched by dilution 
with 1 M HCl (5 mL) and MeCN (1 mL). The aqueous layer was extracted with EtOAc (3 x 5 
mL) and the combined organic layers were washed with saturated aqueous NaHCO3 (15 mL).  
The aqueous was back extracted with EtOAc (10 mL) and the combined organic layers were 
dried (Na2SO4), filtered, and concentrated. The product 3a was formed in a 7:1 ratio of 
diastereomers favoring the exo diastereomer (determined by 1H NMR analysis of the crude 
reaction mixture) and purified by silica gel chromatography (0:100 to 10:90 EtOAc:hexanes) to 
yield 32.7 mg (39% yield) of the combined diastereomers as a yellow oil.  The enantiomeric 
excess of the exo diastereomer was determined to be 98% by chiral SFC analysis (OJ-H, 2.5 
mL/min, 3% IPA in CO2, λ = 254 nm): tR(major) = 12.5 min, tR(minor) = 10.9 min.  The 
enantiomeric excess of the endo diastereomer was determined to be 92% by chiral SFC analysis 
(OJ-H, 2.5 mL/min, 3% IPA in CO2, λ = 254 nm): tR(major) = 5.8 min, tR(minor) = 5.0 min.  
Spectral data are in agreement with the literature.24     
                                                        25 For more information regarding Table 5, entry 3, see reference 24.   
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3a (Table 5, entry 4): racemic 
 
 
 
 
 
 
 
3a (Table 5, entry 4): enantioenriched, exo: 98% ee, endo: 92% ee 
 
  
N
TFA
N
Me
Me
CO2Bn
H
exo-3a 
racemic
N
TFA
N
Me
Me
CO2Bn
H
endo-3a 
racemic
N
TFA
N
Me
Me
CO2Bn
H
exo-3a 
98% ee
N
TFA
N
Me
Me
CO2Bn
H
endo-3a 
92% ee
